<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_MxJhVhE">The Nature, Assessment, and Treatment of Obsessive-Compulsive Disorder</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>BA</roleName><forename type="first">Joseph</forename><forename type="middle">F</forename><surname>Mcguire</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Psychology , University of South Florida , Tampa , FL ;</note>
								<orgName type="department">Department of Psychology</orgName>
								<orgName type="institution">University of South Florida</orgName>
								<address>
									<settlement>Tampa</settlement>
									<region>FL</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Adam</forename><forename type="middle">B</forename><surname>Lewin</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Department of Pediatrics , University of South Florida , Tampa , FL</note>
								<orgName type="department">Department of Pediatrics</orgName>
								<orgName type="institution">University of South Florida</orgName>
								<address>
									<settlement>Tampa</settlement>
									<region>FL</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Betty</forename><surname>Horng</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Department of Pediatrics , University of South Florida , Tampa , FL</note>
								<orgName type="department">Department of Pediatrics</orgName>
								<orgName type="institution">University of South Florida</orgName>
								<address>
									<settlement>Tampa</settlement>
									<region>FL</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Tanya</forename><forename type="middle">K</forename><surname>Murphy</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Department of Pediatrics , University of South Florida , Tampa , FL</note>
								<orgName type="department">Department of Pediatrics</orgName>
								<orgName type="institution">University of South Florida</orgName>
								<address>
									<settlement>Tampa</settlement>
									<region>FL</region>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><roleName>PhD</roleName><forename type="first">Eric</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
							<email>estorch@health.usf.edu</email>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Psychology , University of South Florida , Tampa , FL ;</note>
								<orgName type="department">Department of Psychology</orgName>
								<orgName type="institution">University of South Florida</orgName>
								<address>
									<settlement>Tampa</settlement>
									<region>FL</region>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Department of Pediatrics , University of South Florida , Tampa , FL</note>
								<orgName type="department">Department of Pediatrics</orgName>
								<orgName type="institution">University of South Florida</orgName>
								<address>
									<settlement>Tampa</settlement>
									<region>FL</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<note type="raw_affiliation">All Children&apos;s Hospital Guild Endowed Chair and Associate Professor, Department of Pediatrics , University of South Florida , 800 6th St. South , Box 7523 , St. Petersburg , FL 33701.</note>
								<orgName type="department" key="dep1">All Children&apos;s Hospital Guild Endowed Chair</orgName>
								<orgName type="department" key="dep2">Department of Pediatrics</orgName>
								<orgName type="institution">University of South Florida</orgName>
								<address>
									<addrLine>800 6th St. South</addrLine>
									<postBox>Box 7523</postBox>
									<postCode>33701.</postCode>
									<settlement>St. Petersburg</settlement>
									<region>FL</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_64FgUwb">The Nature, Assessment, and Treatment of Obsessive-Compulsive Disorder</title>
					</analytic>
					<monogr>
						<idno type="ISSN">-0032-5481, e</idno>
					</monogr>
					<idno type="MD5">1AADCDAA87E0FE9DA0EC0BB63A20450C</idno>
					<idno type="DOI">10.3810/pgm.2012.01.2528</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T09:16+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_Fw7Ev2x">obsessive-compulsive disorder</term>
					<term xml:id="_DFh7cyC">assessment</term>
					<term xml:id="_qCPNnNw">treatment</term>
					<term xml:id="_GAncxSM">phenomenology</term>
					<term xml:id="_X3HkKur">etiology Nature, Assessment, and Treatment of OCD</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_HkYxw9G"><p xml:id="_WSaxCqf"><s xml:id="_4x8jxej">Obsessive-compulsive disorder (OCD) is an anxiety disorder that affects between 1% to 2% of individuals and causes considerable impairment and disability.</s><s xml:id="_mqA4na5">Although .</s><s xml:id="_D29DrJc">50% of individuals experience symptom onset in childhood, symptoms can continue to develop throughout adulthood.</s><s xml:id="_2chXyZf">Accurate and timely assessment of clinical presentation is critical to limit impairment and improve prognosis.</s><s xml:id="_CR3NK5B">Presently, there are 2 empirically supported treatments available for OCD in children and adults, namely cognitive-behavioral therapy and pharmacotherapy with serotonin reuptake inhibitors.</s><s xml:id="_nQsT8mC">This article provides an introduction to the phenomenology, etiology, and clinical course of OCD.</s><s xml:id="_vjRudpY">Assessment practices used to evaluate symptom severity are described, and evidence-based treatment options are reviewed, with appropriate distinctions drawn between children and adults.</s><s xml:id="_nugzhjA">Finally, recommendations for assessment and treatment practices for OCD are explicated.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="634.32" lry="833.04"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="612.0" lry="783.0"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="612.0" lry="783.0"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="612.0" lry="783.0"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="612.0" lry="783.0"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="612.0" lry="783.0"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="612.0" lry="783.0"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="612.0" lry="783.0"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="612.0" lry="783.0"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="612.0" lry="783.0"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="612.0" lry="783.0"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="612.0" lry="783.0"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="612.0" lry="783.0"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="612.0" lry="783.0"/>
		<surface n="15" ulx="0.0" uly="0.0" lrx="612.0" lry="783.0"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_fcE4SDd">Introduction</head><p xml:id="_WMUaYWy"><s xml:id="_cfYDc7W">Obsessive-compulsive disorder (OCD) is an impairing condition that affects 1% to 2% of individuals <ref type="bibr" target="#b19">1</ref> and causes considerable impairment in both children and adults, <ref type="bibr" target="#b20">[2]</ref><ref type="bibr" target="#b21">[3]</ref><ref type="bibr" target="#b22">[4]</ref> often leading to diminished quality of life. <ref type="bibr" target="#b23">5,</ref><ref type="bibr" target="#b24">6</ref></s><s xml:id="_eK5RHJ9">The World Health Organization considers OCD to be a leading cause of disability in the developed world. <ref type="bibr" target="#b25">7</ref></s><s xml:id="_n44eVVm">Given these concerns, there is a clear need to inform practitioners about the clinical course of OCD, as well as the empirically supported assessment and treatment practices.</s><s xml:id="_wDwX8xN">This article serves as a primer on the phenomenology, etiology, clinical course, and comorbid conditions associated with OCD.</s><s xml:id="_KW7evBj">Additionally, assessment modalities and evidence-based treatment options are reviewed.</s><s xml:id="_qKNREaw">Because there are differences in clinical presentation between children and adults, distinctions are addressed when appropriate.</s><s xml:id="_3Zrgw7u">This article concludes with practical recommendations on the assessment and treatment of OCD and highlights aspects that are integral to improving patient outcomes.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_KnUYaW4">Phenomenology</head><p xml:id="_SaJSYWw"><s xml:id="_XKDJnJS">Traditionally conceptualized as an anxiety disorder, OCD is characterized by the presence of obsessions and/or compulsions that are time-consuming and cause distress and/or interference.</s><s xml:id="_nxGH5ZX">Obsessions are recurrent and persistent thoughts, impulses, or images that are experienced as inappropriate, intrusive, and distressing.</s><s xml:id="_6utFa4R">Intrusive thoughts are frequently reported by nonclinical samples of children (77%-85%) <ref type="bibr" target="#b26">8,</ref><ref type="bibr" target="#b27">9</ref> and adults (80%-88%). <ref type="bibr" target="#b28">10,</ref><ref type="bibr" target="#b0">11</ref></s><s xml:id="_nFEmfbs">However, obsessions experienced by patients with OCD differ from those encountered by nonclinical populations in terms of the extent of distress, time lost, or impairment.</s><s xml:id="_v3eNYuk">Common obsessions in patients with OCD include contamination fears (eg, dirt, germs, chemicals), fear of harm to self or others, preoccupations with symmetry, exactness, or order, excessive concerns regarding religious or moral conduct (eg, fear of committing a sin, breaking rules, or displeasing God), fixations with lucky or unlucky numbers, or forbidden sexual, aggressive, or violent thoughts or images. <ref type="bibr" target="#b1">[12]</ref><ref type="bibr" target="#b2">[13]</ref></s><s xml:id="_fM73uGD">3]<ref type="bibr" target="#b3">[14]</ref> Although these individuals are highly unlikely to act out on obsessive thoughts, they produce considerable distress and frustration.</s></p><p xml:id="_P6HPRcM"><s xml:id="_uq8PQBZ">In response to obsession-related distress, individuals with OCD engage in repetitive behaviors or mental acts called compulsions to provide temporary relief by neutralizing the fear.</s><s xml:id="_GQd3MWS">Compulsions are generally excessive and repetitive (eg, washing hands 25 times after touching a "contaminant"), cause considerable impairment, and/or are irrational means of preventing feared outcomes evoked by obsessions (eg, avoid stepping on cracks to save mother's back).</s><s xml:id="_RPAjJ8d">Commonly endorsed compulsions include decontamination rituals (eg, excessive washing, bathing, or cleaning), checking (eg, doors, locks, homework), counting, repeating, and straightening. <ref type="bibr" target="#b1">[12]</ref><ref type="bibr" target="#b2">[13]</ref></s><s xml:id="_HMFNgNy">]<ref type="bibr" target="#b3">[14]</ref> Other rituals may include confessing/praying, reassurance seeking, touching, tapping, and rubbing, measures to prevent harm to self or others, and hoarding. <ref type="bibr" target="#b1">[12]</ref><ref type="bibr" target="#b2">[13]</ref></s><s xml:id="_6Rvkp9z">3]<ref type="bibr" target="#b3">[14]</ref> Individuals with OCD tend to have several obsessions and compulsions, with certain obsessions linked to the performance of specific compulsions (eg, fears of contamination with washing rituals).</s><s xml:id="_ka8pRsp">As opposed to performing compulsions to alleviate or prevent distressing obsessions, individuals may actively avoid antecedents that precipitate obsessions or compulsions.</s><s xml:id="_mwcWXPg">Avoidance is relatively frequent in patients with OCD <ref type="bibr" target="#b3">[14]</ref><ref type="bibr" target="#b4">[15]</ref><ref type="bibr" target="#b5">[16]</ref> and is directly associated with symptom severity and overall clinical severity. <ref type="bibr" target="#b6">17</ref></s><s xml:id="_6ydqHkf">lthough obsessive-compulsive symptoms are heterogeneous across patients, symptoms appear to cluster together to form identifiable dimensional categories.</s><s xml:id="_tEvw7Qq">Patients may endorse symptoms on several symptom dimensions, with a preponderance of symptoms falling into 1 or more dimensional groupings that are relatively stable across the lifespan. <ref type="bibr" target="#b7">18,</ref><ref type="bibr" target="#b8">19</ref></s><s xml:id="_fruukVB">Four primary obsessive-compulsive symptom dimensions have been noted: 1) symmetry, which includes symmetry obsessions and ordering, repeating, and counting compulsions; 2) forbidden thoughts, which include aggression, sexual and/or religious obsessions, and checking; 3) cleaning, which includes contamination obsessions and cleaning compulsions; and 4) hoarding, which includes hoarding-specific obsessions and compulsions.</s><s xml:id="_3Mr6ggY">Symptom dimensions have been associated with distinct patterns of psychiatric comorbidity, 20 heritability, <ref type="bibr" target="#b10">21,</ref><ref type="bibr" target="#b11">22</ref> and patterns of neural activity, as measured by functional magnetic resonance imaging. <ref type="bibr" target="#b12">23</ref></s><s xml:id="_HSmsHGm">Moreover, specific symptom dimensions have been associated with differential response to pharmacologic (Table <ref type="table">1</ref>) <ref type="bibr" target="#b13">24,</ref><ref type="bibr" target="#b14">25</ref> and nonpharmacologic (Table <ref type="table" target="#tab_1">2</ref>) treatments, <ref type="bibr" target="#b15">26,</ref><ref type="bibr" target="#b16">27</ref> as well as decreased likelihood of symptom remission in adulthood. <ref type="bibr" target="#b17">28</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_FDrhARK">Etiology</head><p xml:id="_hQrb77u"><s xml:id="_B6JeZ4g">A definitive account of the etiology of OCD is not yet available, although most agree that it is multifactorial.</s><s xml:id="_vFchdxu">Several prevailing theories regarding the onset and maintenance of obsessive-compulsive symptoms are described below, including neurobiological, genetic, and cognitive-behavioral perspectives.</s><s xml:id="_4HfSn4Z">Although there is a growing literature on the neurobiology of OCD, replications of study findings are relatively limited.</s><s xml:id="_Ztg7AuM">A wide range of biological models have proposed that the development and maintenance of obsessivecompulsive symptoms are linked to abnormal functioning of brain regions, specifically dysfunction in the orbitofrontal cortex (OFC), anterior cingulated cortex (ACC), frontal cortex, parietal cortex, thalamus, and caudate nucleus. <ref type="bibr" target="#b18">[29]</ref><ref type="bibr" target="#b30">[30]</ref></s><s xml:id="_6F3DVsw">]<ref type="bibr" target="#b31">[31]</ref><ref type="bibr" target="#b32">[32]</ref> However, a meta-analysis of 13 functional neuroimaging studies found that differences between patients with OCD and controls were not replicated. <ref type="bibr" target="#b31">31</ref></s><s xml:id="_eCGyVB3">n light of the potential brain regions implicated in OCD (eg, OFC, thalamus, and ACC), there has been interest in exploring the role of the basal ganglia, particularly the dysfunction of cortico-striatal-thalamic-cortical (CSTC) circuits. <ref type="bibr" target="#b33">33,</ref><ref type="bibr" target="#b34">34</ref></s><s xml:id="_B9JwGZV">he CSTC model suggests that obsessive-compulsive symptoms develop from dysfunctional pathways that connect the caudate nucleus, OFC, and ACC (see Del Casale et al <ref type="bibr" target="#b35">35</ref> for a comprehensive review).</s><s xml:id="_z9QZMZq">This model suggests that "direct" and "indirect" pathways through the basal ganglia account for excitatory and inhibitory responses, respectively.</s><s xml:id="_NBCeNnz">Imaging studies in patients with OCD indicate that the OFC, ACC, and caudate nucleus are hyperactive at rest, become more active under symptom provocation, and show less activity following treatment. <ref type="bibr" target="#b18">29,</ref><ref type="bibr" target="#b30">30,</ref><ref type="bibr" target="#b33">33</ref></s><s xml:id="_CKEwgGN">As there are multiple circuits connecting these regions, a deficit may be present at any point in the pathway, triggering dysfunction in other connected areas. <ref type="bibr" target="#b18">29,</ref><ref type="bibr" target="#b30">30</ref></s><s xml:id="_DzyuQwN">This may account for the heterogeneous symptomatic presentation observed in patients with OCD.</s><s xml:id="_HzbQcXY">Neuropsychological functioning affected by these CSTC circuits is involved in decision making, learning, and adaptive functioning, all of which have been suggested as being impaired in patients with OCD (eg, deficits in set shifting abilities, decision making, and learning). <ref type="bibr" target="#b36">36,</ref><ref type="bibr" target="#b37">37</ref></s><s xml:id="_a8GZTAa">Lending further support to this model are the findings that successful treatment of OCD is associated with attenuation of abnormal regional brain activity within the OFC, ACC, and caudate nucleus. <ref type="bibr" target="#b38">[38]</ref><ref type="bibr" target="#b39">[39]</ref></s><s xml:id="_GS8cRuq">]<ref type="bibr" target="#b40">[40]</ref><ref type="bibr" target="#b41">[41]</ref> Obsessive-compulsive disorder appears to have a genetic component, which has been shown by an increased risk in both twin studies and in first-degree relatives of patients with OCD. <ref type="bibr" target="#b42">42,</ref><ref type="bibr" target="#b43">43</ref></s><s xml:id="_sPC7hPR">Prevalence rates in first-degree relatives vary across studies (10%-35%), with lifetime prevalence of OCD being significantly higher in case (22.5%) rather than control (2.6%) first-degree relatives. <ref type="bibr" target="#b43">[43]</ref><ref type="bibr" target="#b44">[44]</ref></s><s xml:id="_jWH5wm8">4]<ref type="bibr" target="#b45">[45]</ref> Familial risk appears to be much greater for childhood-onset OCD compared with adult-onset OCD. <ref type="bibr" target="#b46">46</ref></s><s xml:id="_SBhwdxd">More than 80 candidate gene studies have been conducted, with a predominant emphasis on genes in the serotonergic and dopaminergic pathways.</s><s xml:id="_hZNshvh">However, none of the identified candidates have achieved genome-wide significance or produced consistent replicated findings. <ref type="bibr" target="#b47">47</ref></s><s xml:id="_4Vckqvw">The glutamate transporter gene (SLC1 A1) on 9p24 has shown early promise of exhibiting a replicable finding in genetic association studies of patients with OCD. <ref type="bibr" target="#b48">48,</ref><ref type="bibr" target="#b49">49</ref></s><s xml:id="_2uxPNzk">n addition to neurobiological and genetic perspectives, OCD etiology can be explicated using behavioral and cognitive models.</s><s xml:id="_DrQQyRq">Two types of conditioning processes occur in the development of OCD.</s><s xml:id="_AeeWnx5">The behavioral model suggests</s></p><p xml:id="_wZZMm5u"><s xml:id="_q2MmUkD">Table 1.</s><s xml:id="_dj9yZjT">Evidence-Based Pharmacotherapy for OCD Medication Recommended Adult Daily Dose Range, mg Randomized Controlled Trials Average Symptom Severity Reductions and Response Rates Tricyclic Antidepressants Clomipramine 75-300 Koran et al 141 (1996) Mundo et al 173 (2000) Foa et al 117 (2005) DeVeaugh-Geiss et al 138 (1992) 7.3 reduction on Y-BOCS with 54% response rate a 12.0 reduction on Y-BOCS with 65% response rate b 8.1 reduction on Y-BOCS with 44% response rate c 10.0 reduction on CY-BOCS SSRIs Fluvoxamine 50-300 Mundo et al 173 (2000) Goodman et al 174 (1989) Goodman et al 175 (1996) Hollander et al 176 (2003) Jenike et al 177 (1990) Riddle et al 178 (2001) 12.3 reduction on Y-BOCS with 62% response rate b 5.6 reduction on Y-BOCS with 36% response rate c 3.9 reduction on Y-BOCS with 43% response rate c 8.5 reduction on Y-BOCS with 45% response rate b 3.8 reduction on Y-BOCS 6.0 reduction on CY-BOCS with 42% response rate a Paroxetine 20-60 Zohar and Judge 144 (1996) Kamijima et al 179 (2004) Geller et al 142 (2004) 8.0 reduction on Y-BOCS with 55% response rate a 8.1 reduction on Y-BOCS with 50% response rate c 8.8 reduction on CY-BOCS with 45% response rate c Sertraline 50-200 Koran et al 180 (2002) Greist et al 181 (1995) Jenike et al 182 (1990) Kronig et al 183 (1999) Bergeron et al 184 (2002) March et al 185 (1998) POTS 115 (2004) 16.5 reduction on Y-BOCS 5.6 reduction on Y-BOCS with 39% response rate c 2.2 reduction on Y-BOCS $ 8.0 reduction on Y-BOCS with 41% response rate c 8.4 reduction on Y-BOCS with 51% response rate c 6.8 reduction on CY-BOCS with 42% response rate c 7.0 reduction on CY-BOCS Citalopram 20-60 Montgomery et al 186 (2001) Alaghband-Rad and Hakimshooshtary 187 (2009) 3.5-5.5 reductions on Y-BOCS with response rates between 57%-65% a (depending on dose) 11.1 reduction on CY-BOCS Escitalopram 10-20 Stein et al 188 (2007) 11.4-12.1 reductions on Y-BOCS (depending on dose) Fluoxetine 20-60 Bergeron et al 184 (2002) Montgomery et al 189 (1993) Jenike et al 143 (1997) Tollefson et al 190 (1994) Liebowitz et al 191 (2002) Riddle et al 192 (1992) Geller et al 193 (2001) 6.1 reduction on Y-BOCS with 39% response rate c 4.8-6.1 reductions on Y-BOCS with response rates between 36%-47% d (depending on dose) 2.8 reduction on Y-BOCS 4.7-7.6 reduction on Y-BOCS with response rates between 32%-35% b (depending on dose) 7.79 reduction on CY-BOCS with 57% response rate c 10.7 reduction on CY-BOCS 9.5 reduction on CY-BOCS with 49% response rate b a Treatment response determined by reductions $ 25% on CY-BOCS/Y-BOCS.</s><s xml:id="_bvQURsB">b Treatment response determined by reductions $ 35% on CY-BOCS/Y-BOCS.</s><s xml:id="_gueHHat">Treatment response determined by either a rating of "very much improved" or "much improved" on the CGI-I.</s></p><p xml:id="_SmH53Tp"><s xml:id="_6sJE6aw">that obsessions develop through classical conditioning, whereby previously neutral stimuli are paired with aversive stimuli, thereby creating a conditioned fear response to the previously neutral stimuli. <ref type="bibr" target="#b50">50</ref></s><s xml:id="_ntqcAZP">Obsessions generate increased distress for patients and precipitate the performance of compulsions (ritualized behaviors), which serve to temporarily alleviate or neutralize obsession-related anxiety.</s><s xml:id="_svP2bpF">The reduction in anxiety/distress (known as negative reinforcement) maintains the compulsive behaviors via operant conditioning.</s><s xml:id="_2djruK3">In a complementary fashion, cognitive models of OCD suggest that obsessive symptoms develop from dysfunctional cognitive beliefs (eg, inflated sense of responsibility, overestimation of threats) that lead to misappraisal and misinterpretation of intrusive thoughts or stimuli. <ref type="bibr" target="#b51">[51]</ref><ref type="bibr" target="#b52">[52]</ref></s><s xml:id="_ZhnNtnz">2]<ref type="bibr" target="#b53">[53]</ref> These misappraisals and misinterpretations cause patients to experience increased distress and anxiety, which result in attempts to control, suppress, or neutralize these thoughts or to prevent harmful consequences by initiating ritualized behaviors or avoidance. <ref type="bibr" target="#b51">51,</ref><ref type="bibr" target="#b54">54</ref></s><s xml:id="_p8k94m7">Notably, this cognitive paradigm may not be universally applicable to patients with OCD, as many of them experience feelings of disgust <ref type="bibr" target="#b55">55</ref> and "not-just-right" feelings as motivations for compulsive rituals. <ref type="bibr" target="#b56">56,</ref><ref type="bibr" target="#b57">57</ref></s><s xml:id="_RVb2a7E">Although it is likely that both conceptualizations are involved in the development and maintenance of obsessive-compulsive symptoms, the behavioral model has served as the basis for empirically supported psychotherapy treatments. <ref type="bibr" target="#b58">58</ref></s><s xml:id="_K4fsTpy">he development of OCD is likely due to a complex interaction of genetic and environmental processes.</s><s xml:id="_mxmHFBt">Many environmental influences have been reported to influence the onset of OCD, including neurological illnesses, trauma, medical illness, and infections. <ref type="bibr" target="#b59">59</ref></s><s xml:id="_jMyMx3X">One example, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus (PANDAS), has received considerable debate and recent attention. <ref type="bibr" target="#b60">60</ref></s><s xml:id="_Bdg22ZU">Briefly, PANDAS refers to childhoodonset OCD (or tic disorders) with abrupt onset or an episodic symptom course, in which symptom onset or exacerbation is temporally associated with infection with Group A Streptococcus (GAS). <ref type="bibr" target="#b61">61</ref></s><s xml:id="_a3EfDNM">However, establishing a clear and definitive causal role of GAS infections has proven difficult, in part because GAS infections are so common in childhood, and other infectious triggers may play a role. <ref type="bibr" target="#b60">60,</ref><ref type="bibr" target="#b62">62</ref></s><s xml:id="_eN8DZXu">In the end, as these pathogenic models are not mutually exclusionary, there may be several contributing factors that lead to the development of obsessive-compulsive symptoms.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_sZ7m2vJ">Clinical Course</head><p xml:id="_pTKSzDa"><s xml:id="_DSKkr7C">Obsessive-compulsive symptoms exhibit a bimodal distribution, with 2 peaks of symptom onset occurring around prepuberty and early adulthood. <ref type="bibr" target="#b19">1,</ref><ref type="bibr" target="#b63">63,</ref><ref type="bibr" target="#b64">64</ref></s><s xml:id="_zFpst9F">For those individuals with a childhood onset, symptoms usually begin between ages 6 and 10 years, with a marked increase in symptom severity around age 11 years. <ref type="bibr" target="#b17">28,</ref><ref type="bibr" target="#b65">65</ref></s><s xml:id="_ehT2ac8">Childhood symptom onset tends to be observed earlier in boys than in girls. <ref type="bibr" target="#b66">66,</ref><ref type="bibr" target="#b67">67</ref></s><s xml:id="_vgsp6u9">Comparatively, obsessive-compulsive symptoms that develop in adulthood tend to have a female preponderance, <ref type="bibr" target="#b68">68</ref> with most of these cases indicating symptomatic development in late adolescence and early adulthood. <ref type="bibr" target="#b19">1,</ref><ref type="bibr" target="#b65">65,</ref><ref type="bibr" target="#b68">68</ref></s><s xml:id="_uv8NWm2">Although there may be sex differences in symptomatic development in childhood and early adulthood, the sex difference equilibrates over time.</s></p><p xml:id="_x4pAnmA"><s xml:id="_arURT8m">Children with OCD often experience severe distress and impairment. <ref type="bibr" target="#b69">69</ref></s><s xml:id="_qfEJ5N4">In children, impaired psychosocial functioning has been documented in academic, familial, and peer/ socialization domains. <ref type="bibr" target="#b20">2,</ref><ref type="bibr" target="#b70">[70]</ref><ref type="bibr" target="#b71">[71]</ref></s><s xml:id="_VZnQVsS">1]<ref type="bibr" target="#b72">[72]</ref><ref type="bibr" target="#b73">[73]</ref> Moreover, symptoms can affect family dynamics, as parent ratings of functional impairment are associated with family accommodation. <ref type="bibr" target="#b74">74,</ref><ref type="bibr" target="#b75">75</ref></s><s xml:id="_c4CMGt7">Without appropriate intervention, obsessive-compulsive symptoms will likely persist into adulthood. <ref type="bibr" target="#b76">76,</ref><ref type="bibr" target="#b77">77</ref></s><s xml:id="_nmVGGZG">Similar to children, adults often experience social, emotional, health-related, and occupational impairment that corresponds with a decreased quality of life. <ref type="bibr" target="#b22">4,</ref><ref type="bibr" target="#b78">[78]</ref><ref type="bibr" target="#b79">[79]</ref></s><s xml:id="_ag4qReX"><ref type="bibr" target="#b80">[80]</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Dvhgv84">Comorbidity</head><p xml:id="_AdU3Jyg"><s xml:id="_dvdsUN7">The co-occurrence of other psychiatric conditions with OCD is relatively frequent, with up to 90% of cases indicating $ 1 comorbid psychiatric disorder. <ref type="bibr" target="#b19">1</ref></s><s xml:id="_KRTcPpV">Non-OCD anxiety disorders, such as generalized anxiety disorder (8%-44%), social phobia (26%-43%), panic disorder (15%-20%), and mood disorders, such as major depressive disorder (20%-78%), are the most common comorbid conditions in adults. <ref type="bibr" target="#b19">1,</ref><ref type="bibr" target="#b65">65,</ref><ref type="bibr" target="#b68">68</ref></s><s xml:id="_8dctRXa">ubstance use/dependence is more frequent in adults <ref type="bibr" target="#b19">1</ref> than in children or adolescents with OCD, <ref type="bibr" target="#b65">65</ref> but is less frequent in adults with OCD compared with adults with other psychiatric diagnoses. <ref type="bibr" target="#b81">81</ref></s><s xml:id="_yMrNpHa">lthough children and adolescents frequently present with comorbid non-OCD anxiety disorders, such as separation anxiety disorder (16%-56%), generalized anxiety disorder (39%-48%), and social phobia (14%-38%), they also tend to exhibit externalizing disorders, such as attention-deficit hyperactivity disorder (ADHD; 10%-51%) and oppositionaldefiant disorder (ODD; 15%-51%). <ref type="bibr" target="#b65">65,</ref><ref type="bibr" target="#b68">68,</ref><ref type="bibr" target="#b82">82</ref></s><s xml:id="_a8FNqbZ">Children may also present with mood disorders, such as major depressive disorder (27%-62%) <ref type="bibr" target="#b65">65,</ref><ref type="bibr" target="#b82">82</ref> and bipolar disorder (15%-34%). <ref type="bibr" target="#b82">82,</ref><ref type="bibr" target="#b83">83</ref></s><s xml:id="_t5cw72G">lthough less frequent in older adolescents and adults, the co-occurrence of tic disorders in children with OCD is fairly common (25%-37%). <ref type="bibr" target="#b65">65,</ref><ref type="bibr" target="#b82">82</ref></s><s xml:id="_5SZhzgj">Additionally, there exists some symptom overlap with autism spectrum disorders, as up to 86% of individuals with autism exhibit compulsions, <ref type="bibr" target="#b84">84</ref> while approximately 20% of individuals with OCD exhibit pronounced autistic traits. <ref type="bibr" target="#b85">85</ref></s><s xml:id="_8vTRq7V">However, there have been no large-scale epidemiological studies conducted to ascertain the comorbidity of autism spectrum disorders and OCD.</s></p><p xml:id="_CTbpZFr"><s xml:id="_tZ5yPeF">From a practitioner's perspective, attention to comorbid conditions is important for several reasons.</s><s xml:id="_x7VXrqN">First, these comorbid conditions may be associated with additional functional impairment beyond the obsessive-compulsive symptoms alone. <ref type="bibr" target="#b21">3,</ref><ref type="bibr" target="#b71">71,</ref><ref type="bibr" target="#b86">86</ref></s><s xml:id="_Ttha34h">Second, certain comorbid conditions may attenuate response to psychotherapy <ref type="bibr" target="#b87">87,</ref><ref type="bibr" target="#b88">88</ref> and/or pharmacotherapy. <ref type="bibr" target="#b89">89</ref></s><s xml:id="_KE9S65g">Third, the presence of certain comorbidities may require sequential or concurrent treatment in addition to addressing obsessive-compulsive symptoms.</s><s xml:id="_5SXATnp">For example, severe depressive symptoms or externalizing problems may require initial treatment so that patients can adequately engage in strategies to treat OCD.</s><s xml:id="_VmFRxbT">Finally, the presence of certain comorbidities may provide information about clinical course for a patient.</s><s xml:id="_eSWS9b7">For instance, the presence of childhood tic disorders has been associated with a greater likelihood of obsessive-compulsive symptom remission in later adulthood. <ref type="bibr" target="#b17">28</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_wkeA83G">Assessment</head><p xml:id="_9KuGzYT"><s xml:id="_MfaPm87">Early and accurate diagnosis of OCD is important for improved patient outcomes.</s><s xml:id="_Xa4Fmp4">When symptoms are suspected, an initial evaluation should include an assessment of current and past OCD symptoms, current symptom severity, associated functional impairment, and psychiatric comorbidity. <ref type="bibr" target="#b90">90</ref></s><s xml:id="_ngakMQd">If the patient does not recognize that the obsessivecompulsive symptoms are excessive or unreasonable, poor insight into symptoms should be specified in the diagnosis, which has implications for clinical severity and treatment outcome. <ref type="bibr" target="#b91">91,</ref><ref type="bibr" target="#b92">92</ref></s><s xml:id="_yryb92N">eyond the unstructured clinical interview, several assessment options exist.</s><s xml:id="_7pD6rga">Structured diagnostic interviews may aid in the diagnosis of OCD and its comorbid conditions.</s><s xml:id="_CCfCc4k">Examples include the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), <ref type="bibr" target="#b93">93</ref> the Kiddie-SADS-Present and Lifetime Version, <ref type="bibr" target="#b94">94</ref> and the Anxiety Disorders Interview Schedules for adults, <ref type="bibr" target="#b95">95</ref> as well as parents and children. <ref type="bibr" target="#b96">96</ref></s><s xml:id="_87K58W5">lthough comprehensive, structured diagnostic interviews are time-intensive and costly, resulting in their infrequent use in regular clinical practice.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ma9bphk">157</head><p xml:id="_XAV29as"><s xml:id="_bc7cUQA">ResearchShare TM : <ref type="url" target="http://www.research-share.com/GetIt">http://www.research-share.com/GetIt</ref></s><s xml:id="_saYee77">â€¢ Copyright Clearance Center: <ref type="url" target="http://www.copyright.com">http://www.copyright.com</ref></s><s xml:id="_7q6EqMd">Clinician-rated scales are the gold standard for evaluating symptom severity.</s><s xml:id="_h79vjdm">The most commonly used measure in adults is the Yale-Brown Obsessive Compulsive Scale (Y-BOCS/Y-BOCS-II).</s><s xml:id="_PxqqPX8">The Y-BOCS/Y-BOCS-II has excellent reliability and validity, <ref type="bibr" target="#b3">14,</ref><ref type="bibr" target="#b97">[97]</ref><ref type="bibr" target="#b98">[98]</ref><ref type="bibr" target="#b99">[99]</ref><ref type="bibr">[100]</ref> with symptom severity reductions between 30% to 45% corresponding with ratings of clinically meaningful improvement. <ref type="bibr">101,</ref><ref type="bibr">102</ref></s><s xml:id="_u9QPBhE">Beyond clinician-rated measures, self-report questionnaires can be used as brief alternatives to assess symptom presence and severity.</s><s xml:id="_Y7WYNbS">Self-report questionnaires, such as the Obsessive Compulsive Inventory-Revised, <ref type="bibr">103</ref> Yale-Brown Obsessive Compulsive Self-Report, <ref type="bibr">104</ref> and the Florida Obsessive-Compulsive Inventory, <ref type="bibr" target="#b2">13</ref> offer informative and reliable ratings of symptom presence and severity (see Benito and Storch 105 for a review of rating scales).</s></p><p xml:id="_7Gmv6qJ"><s xml:id="_EdAr3g2">As children are often secretive about their symptoms and may have limited insight, evaluations for youth should include perspectives from multiple informants. 106,107</s><s xml:id="_TcwcTXw">Moreover, multiple informants help to distinguish obsessivecompulsive symptoms from normative, ritualistic behaviors in early childhood.</s><s xml:id="_HkbtYEZ">The Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS) is a clinician-administered rating scale that assesses the presence and severity of obsessive-compulsive symptoms. 108,109</s><s xml:id="_WkvrP4u">Ratings of symptom severity reductions around 25% correspond with clinically meaningful improvement. <ref type="bibr">110</ref></s><s xml:id="_z45B8N8">In line with multi-informant practices, parent-and child-report measures are often both used.</s><s xml:id="_JDaP5Rf">The Children's Obsessive Compulsive Inventory-Parent and Child reports 111 assess parent-and self-rated symptom presence and severity.</s><s xml:id="_KxnsPPf">Other child-report measures used to assess current symptom severity include the Children's Florida Obsessive-Compulsive Inventory 112 and the Obsessive Compulsive Inventory-Child Version 113 (see Merlo et al 114 for a review of child rating scales).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_sNRZcmq">Treatment</head><p xml:id="_cpd8muj"><s xml:id="_mw3YGVr">There are 2 evidence-based treatment options for OCD: cognitive-behavioral therapy (CBT) and pharmacotherapy.</s><s xml:id="_UhVPPFP">Cognitive-behavioral therapy is a first-line treatment with robust efficacy in treating obsessive-compulsive symptoms in both children and adults. <ref type="bibr">[115]</ref><ref type="bibr">[116]</ref></s><s xml:id="_HQzN8qW">6]<ref type="bibr">[117]</ref><ref type="bibr">[118]</ref> It is recommended as the initial choice of treatment for children and adults with symptoms of mild to moderate severity. <ref type="bibr">106,</ref><ref type="bibr">119</ref></s><s xml:id="_7wEfSyp">If symptom severity persists after CBT, evidence-based pharmacotherapy presents another first-line treatment option that is often more accessible than CBT and yields significant reductions in symptom severity.</s><s xml:id="_qsSctK3">Children and adults who present with symptoms of moderate to severe severity should initially receive both CBT and evidence-based pharmacotherapy. <ref type="bibr">106,</ref><ref type="bibr">119</ref></s><s xml:id="_4C8vkVp">For adults with severe symptom severity, evidence-based pharmacotherapy is recommended as the initial treatment followed by a trial of CBT. <ref type="bibr">119,</ref><ref type="bibr">120</ref></s><s xml:id="_mF4Qn4V">T Cognitive-behavioral therapy for OCD can consist of varied components, such as psychoeducation, cognitive restructuring, and parental involvement. <ref type="bibr">121</ref></s><s xml:id="_6ZQMhTz">Although there is some support for cognitive therapy alone for the treatment of OCD, 122 the predominant therapeutic component relied on in CBT is behavioral, namely exposure and response prevention.</s><s xml:id="_SrShWNU">The exposure component requires the patient to repeatedly encounter situational and/or internal triggers to their anxiety, which usually precipitate their compulsive behaviors.</s><s xml:id="_J62G67f">While completing these exposures, patients must resist engaging in compulsions until habituation to the anxious state is achieved.</s><s xml:id="_WZbU6F6">As patients habituate to feared stimuli, distress and associated desire to ritualize diminishes.</s><s xml:id="_tQPvh6K">For example, a patient who experiences contamination fears and compulsive washing rituals would be required to touch perceived "contaminated" objects (eg, doorknobs that have been touched by multiple individuals) while refraining from cleansing behaviors that function to neutralize his or her fear.</s><s xml:id="_XbRyDpk">Although it may take several therapy sessions before observable improvement is achieved, considerable symptom severity reductions are regularly endorsed across randomized studies 118,123 (Table <ref type="table" target="#tab_1">2</ref>).</s><s xml:id="_sFUxUfF">Although CBT typically occurs on a once-or twice-weekly basis, intensive (daily) CBT produces similar symptom reductions, achieves meaningful response in less overall time, <ref type="bibr">117,</ref><ref type="bibr">124,</ref><ref type="bibr">125</ref> and may be particularly helpful for those who do not respond to pharmacotherapy and/or less intensive psychotherapy. <ref type="bibr">126</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_PjHUF5J">Challenges of CBT</head><p xml:id="_YVdVdGj"><s xml:id="_DYcxFCn">Although CBT has demonstrated lasting improvements for up to 7 years, 127,128 CBT response and delivery can be impeded by patient noncompliance, attrition, and limited access to trained providers.</s><s xml:id="_DyFtbDK">While these challenges impact the use of psychotherapy across many psychiatric disorders, innovative solutions are being explored to address these issues.</s><s xml:id="_mtsBG4A">For example, positive treatment expectations and homework compliance are key aspects of CBT that predict treatment response. <ref type="bibr">129</ref></s><s xml:id="_Cj3UgC7">However, exposure therapy and accompanying homework can sometimes prove challenging to patients, which, in turn, can precipitate noncompliance with therapeutic exposures and discontinuation of treatment.</s><s xml:id="_TdXqJUN">For these challenged patients, the addition of motivational interview-ing to CBT may increase the compliance with exposures by clarifying intrinsic motivation to change behaviors and reduce treatment ambivalence. <ref type="bibr">130,</ref><ref type="bibr">131</ref></s><s xml:id="_FPVjzKU">imited access to cognitive-behavioral treatments is a relatively common problem for patients with anxiety disorders.</s><s xml:id="_V6KKkpz">Emerging technologies (eg, video conferencing, the internet) have demonstrated promise at increasing access for patients by delivering CBT across considerable distances. <ref type="bibr">132</ref></s><s xml:id="_TZVNaNf"> recent study found significant symptom severity reductions when using a web camera to deliver CBT to pediatric OCD patients. <ref type="bibr">133</ref></s><s xml:id="_Wn4bACf">These findings hold considerable promise for treatment dissemination.</s><s xml:id="_4aPttpC">Before encouraging the widespread practice of web-based CBT, further clarification of ethical issues related to telemedicine across state and country borders is needed, along with a larger trial replicating these results. <ref type="bibr">133</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_8PpdaD2">Pharmacotherapy</head><p xml:id="_xwdvG6j"><s xml:id="_PVJfzZt">In addition to CBT, several pharmacologic agents have demonstrated efficacy in reducing obsessive-compulsive symptoms for both children and adults. <ref type="bibr" target="#b64">64,</ref><ref type="bibr">134,</ref><ref type="bibr">135</ref></s><s xml:id="_TbcdRRP">The combination of evidence-based pharmacotherapy with CBT provides considerable benefit, especially to patients with symptoms of moderate to severe severity, or those who do not experience improvement with 1 treatment modality alone. <ref type="bibr">136</ref></s><s xml:id="_t9gX6Vc">erotonin reuptake inhibitors (SRIs), which encompass a specific tricyclic antidepressant (clomipramine), and selective serotonin reuptake inhibitors (SSRIs) have the largest available research base.</s><s xml:id="_TxEETGA">Currently, 5 SRIs-clomipramine, fluvoxamine, fluoxetine, sertraline, and paroxetine-have been approved by the US Food and Drug Administration (FDA) for the treatment of adults, with 4 of these-clomipramine, fluvoxamine, fluoxetine, and sertraline-receiving approval for treatment of children and adolescents with OCD.</s></p><p xml:id="_Ff8b3Tp"><s xml:id="_VpbyzCT">Clomipramine, a tricyclic antidepressant that inhibits the reuptake of serotonin, norepinephrine, and dopamine, was the first pharmacological agent to demonstrate efficacy in reducing obsessive-compulsive symptoms. <ref type="bibr">137,</ref><ref type="bibr">138</ref></s><s xml:id="_8yCbBht">Despite its therapeutic benefit (Table <ref type="table">1</ref>), clomipramine is accompanied by potential cardiovascular complications, anticholinergic effects (eg, dry mouth, headaches, increased heart rate), sedation, weight gain, and sexual dysfunction, which limit its tolerability. <ref type="bibr">137</ref></s><s xml:id="_5H2EN73">Despite its tolerability concerns and associated risks, meta-analyses suggest that clomipramine may be more efficacious than SSRIs in reducing symptom severity. <ref type="bibr" target="#b89">89,</ref><ref type="bibr">116,</ref><ref type="bibr">139</ref></s><s xml:id="_t9yGHzV">However, direct-comparison clinical trials with fluoxetine and fluvoxamine have failed to detect a difference in efficacy. <ref type="bibr">140,</ref><ref type="bibr">141</ref></s><s xml:id="_HfKZ8hV">lective serotonin reuptake inhibitors (eg, fluvoxamine, fluoxetine, sertraline, citalopram, and escitalopram) increase synaptic serotonin concentrations by inhibiting its reuptake into the presynaptic neuron.</s><s xml:id="_XH8kXVY">The efficacy of SSRIs is well established in the treatment of OCD, with variable reductions in symptom severity for each specific pharmacological agent (Table <ref type="table">1</ref>).</s><s xml:id="_UvA8Qaz">These symptom severity reductions should be considered against reductions observed with placebo in children (2.3-5.3 on the CY-BOCS) <ref type="bibr">138,</ref><ref type="bibr">142</ref> and adults (0.20-5.0 on the Y-BOCS). <ref type="bibr">143,</ref><ref type="bibr">144</ref></s><s xml:id="_SWychM6">Although there appears to be no systematic efficacy differences between specific SSRI medications, <ref type="bibr">116,</ref><ref type="bibr">145</ref> individual patients may respond to or tolerate 1 SSRI instead of another. <ref type="bibr">119</ref></s><s xml:id="_2nVbhNH">In the absence of an adverse reaction, a minimum 12-week SSRI trial is recommended to evaluate the medication's therapeutic benefit before transitioning to another medication. <ref type="bibr">146</ref></s><s xml:id="_Afw4hVJ">ompared with other conditions for which antidepressants are effective at lower doses (eg, non-OCD anxiety disorders and major depressive disorder), many experts advocate the use of higher and quickly escalating doses of an SSRI in the treatment of OCD. 119,120</s><s xml:id="_gJnve3J">A meta-analysis of fixed-dosed trials in adults with OCD found evidence to suggest that higher SSRI doses are more effective in the treatment of adults with OCD. <ref type="bibr">147</ref></s><s xml:id="_bcM8XWJ">Despite good efficacy, SSRIs are frequently accompanied by side effects, including nausea, dyspepsia, diarrhea, constipation, headache, insomnia, anxiety, fatigue, sedation, somnolence, asthenia, forgetfulness, and sexual dysfunction. <ref type="bibr">145</ref></s><s xml:id="_wRAfkpM">Attention to side effects is important, as they can influence patient compliance with medication regimens and treatment attrition rates. <ref type="bibr">116</ref></s><s xml:id="_8Ah3r4h">In children, clinicians should be particularly vigilant for behavioral activation, 148 a phenomenon involving agitation, hostility, restlessness, impulsivity, emotional lability, and insomnia.</s><s xml:id="_weqZQbQ">Notably, these symptoms are most often seen 1 to 9 days after a dose change. 106,149</s><s xml:id="_trNVdQm">A small but significant increased risk of suicidality in youth taking SSRIs led the FDA to issue a black box warning to inform parents and clinicians of these associated risks.</s><s xml:id="_K8HaWr4">However, subsequent meta-analyses concluded that SSRIinduced benefit outweighs the risk of a suicide event among OCD-affected youth. <ref type="bibr">150</ref></s><s xml:id="_h7xxAZQ">Nonetheless, caution is encouraged when considering medication for children and adolescents.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_q6A8AV3">Augmentation of SRIs</head><p xml:id="_M7299t2"><s xml:id="_KvMkmXk">Serotonin reuptake inhibitors are an acceptable monotherapy option; however, between 40% to 60% of patients with OCD do not respond to adequate trials of these medications. <ref type="bibr">151</ref></s><s xml:id="_5xstd7v">oreover, residual symptoms frequently exist, with remission being less common with SRI medication (8%-37%) than with CBT (24%-55%). <ref type="bibr">152</ref></s><s xml:id="_qmxgqJH">Consequently, SSRI augmentation with other pharmacological agents, such as antipsychotics (eg, haloperidol, 153 aripiprazole, 154,155 quetiapine, 156-159 risperidone 160 ), clomipramine, 161 and benzodiazepines, 162 have been investigated.</s><s xml:id="_wSMGSYk">While findings in this area are preliminary, the most beneficial SRI augmentation with antipsychotics appears to come from risperidone 163 and aripiprazole. <ref type="bibr">154,</ref><ref type="bibr">164</ref></s><s xml:id="_nyfp4a8">However, antipsychotic augmentation practices are frequently accompanied by significant side effects that may limit their tolerability and prolonged use (eg, weight gain, metabolic dysregulation, sedation), <ref type="bibr">165</ref> and their long-term efficacy remains uncertain. <ref type="bibr">166</ref></s><s xml:id="_tCs3GJN">Beyond antipsychotics, another group of medications acting on glutamate (eg, memantine, N-acetylcysteine) have shown promise as augmenting agents. <ref type="bibr">167,</ref><ref type="bibr">168</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_EgvM3WJ">Discussion</head><p xml:id="_8TCzsQU"><s xml:id="_pzBpqNC">Considerable advances have led to an improved understanding of the nature, assessment, and treatment of OCD.</s><s xml:id="_BYWm2xs">Initially, patients experienced an average of 17 years between the development of obsessive-compulsive symptoms and the start of appropriate treatment. <ref type="bibr">169</ref></s><s xml:id="_NnRZWGh">Now, patients spend approximately 9 years before receiving evidence-based care. <ref type="bibr" target="#b19">1</ref> Although progress has been made, there are still reports of up to 50% of children being referred to an OCD specialty clinic who have not previously received an evidence-based treatment (ie, medication or CBT). <ref type="bibr">170</ref></s><s xml:id="_xwMBRZt">The findings among adults reflect a similar pattern of limited dissemination for effective treatments (eg, CBT). <ref type="bibr">171</ref></s><s xml:id="_Vuqysam">Clearly, further clinical and research efforts are necessary to improve the timely assessment and treatment of OCD.</s></p><p xml:id="_uYtMS9G"><s xml:id="_z223mGG">In terms of advancing the assessment of OCD, early and accurate identification of symptoms is an integral component.</s><s xml:id="_ztrrCTE">The development of obsessive-compulsive symptoms frequently occurs amid the presence of other anxiety or mood disorders that complicate accurate recognition. <ref type="bibr" target="#b19">1</ref> Consequently, clinicians are encouraged to be attentive to the presence of obsessive-compulsive symptoms when evaluating patients for common comorbid conditions.</s><s xml:id="_gwbvmTR">The use of reliable rating scales (as discussed above) assists in clarifying symptom presentation, evaluating symptom severity, and tracking the clinical course of treatment.</s></p><p xml:id="_9sRuX8z"><s xml:id="_vgYYnn5">Evidence-based treatments are recommended for patients with OCD across the lifespan.</s><s xml:id="_RvUF2KW">Cognitive-behavioral therapy should be the first-line intervention except in severe cases or when access is unavailable.</s><s xml:id="_ZkTFs8J">Moreover, the "active ingredient" in CBT is exposure and response prevention (ie, facing the feared stimulus, habituating to anxiety, and refraining from rituals).</s><s xml:id="_XRWG3Rm">Although finding well-trained therapists specializing in OCD can be difficult, there are several online professional directories that can provide information concerning available therapists in patients' local areas (eg, International OCD Foundation, Association of Behavioral and Cognitive Therapies' "Find-a-Therapist").</s><s xml:id="_XkUZAmv">As access and availability can pose problems for CBT use, researchers are developing innovative methods of CBT dissemination (eg, computer-based CBT programs, web camera CBT) to further increase access to this evidence-based treatment.</s><s xml:id="_V8Jxymv">If a patient's symptom presentation is severe or worsens significantly, intensive (eg, daily) outpatient CBT as well as specialized residential programs are available.</s><s xml:id="_jMrnmX3">Because these programs might not be accessible for some families (eg, due to location or cost), 172 medication should also be considered.</s></p><p xml:id="_ktahp3W"><s xml:id="_X4mhBKd">When CBT is inaccessible or insufficient, SRI medications present another evidence-based treatment option.</s><s xml:id="_8qmX7Pz">These pharmacological agents are often more accessible than CBT (eg, primary care physician) and yield modest but significant reductions in obsessive-compulsive symptom severity.</s><s xml:id="_JJJZj2S">It is important that patients receive an adequate trial of an SRI (minimum of 12 weeks <ref type="bibr">119,</ref><ref type="bibr">146</ref> ) before transitioning to a different SRI medication.</s><s xml:id="_VwcKhMU">These medications are generally well tolerated but may be accompanied by side effects, and should be prescribed with care for pediatric patients.</s><s xml:id="_QYZb6V9">For patients with severe symptoms, who have no access to CBT (or demonstrate poor response to it) and exhibit only a moderate response to adequate trials of SRIs, evidence-based treatment options are less definitive.</s><s xml:id="_8j2qzbf">In clinical practice, antipsychotic medications (eg, risperidone, aripiprazole) have shown efficacy in SRI augmentation in adults.</s><s xml:id="_XHjRzQQ">However, in such situations, it is prudent to refer to a psychiatrist before pursuing this course of treatment.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_MkKAdvv">Conclusion</head><p xml:id="_3mH4wFP"><s xml:id="_qXtZf2h">Collaborative efforts of clinical researchers and practitioners have led to improvements in treatment outcomes and quality of life for patients with OCD.</s><s xml:id="_Zm8Urqd">Through continued collaboration and implementation of evidence-based practices, timely symptom recognition and early evidence-based care can be initiated to improve the outcomes and quality of life for children, adolescents, and adults with OCD.</s></p><p xml:id="_z9RJqQu"><s xml:id="_xtwKKSG">National Alliance for Research on Schizophrenia and Affective Disorders, Otsuka Pharmaceuticals, Forest Pharmaceuticals, Ortho-McNeil Janssen Pharmaceuticals, Shire Pharmaceuticals, and Indevus Pharmaceuticals.</s><s xml:id="_E7Sy38B">She receives travel support from the Tourette Syndrome Association and honorarium from the Arizona Psychiatric Association.</s><s xml:id="_5DcBnZR">Eric A. Storch, PhD has received grant funding in the last 3 years from the National Institutes of Health, All Children's Hospital Research Foundation, the Centers for Disease Control and Prevention, the National Alliance for Research on Schizophrenia and Affective Disorders, the International OCD Foundation, Tourette Syndrome Association, Janssen Pharmaceuticals, and the Foundation for Research on Prader-Willi Syndrome.</s><s xml:id="_cPXb7hm">He receives textbook honorarium from Springer publishers, the American Psychological Association, and Lawrence Erlbaum.</s><s xml:id="_sgzHGDB">Dr. Storch has been an educational consultant for Memorial Hospital.</s><s xml:id="_3NMMSBm">He is a consultant for Prophase, Inc. and is on the speakers' bureau and scientific advisory board for the International OCD Foundation.</s><s xml:id="_UTgtq6T">He receives research support from All Children's Hospital Guild Endowed Chair.</s><s xml:id="_ZdecHrE">Joseph F. McGuire, BA and Betty Horng, PhD disclose no conflicts of interest.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><figDesc><div><p xml:id="_Rmefutn"><s xml:id="_TRs9GfZ">c</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p xml:id="_JWvnJHh"><s xml:id="_bkCCG7M">Exposure-Based Cognitive-Behavioral Therapy for OCD</s></p></div></figDesc><table><row><cell>Randomized</cell><cell>Duration of</cell><cell>Sessions, N</cell><cell>Average Symptom Severity Reduction and</cell></row><row><cell>Controlled Trials</cell><cell>Treatment, wk</cell><cell></cell><cell>Response Rate</cell></row><row><cell>Weekly Treatment</cell><cell></cell><cell></cell><cell></cell></row><row><cell>POTS 115 (2004)</cell><cell>12</cell><cell>14</cell><cell>12.0 reduction on CY-BOCS</cell></row><row><cell>Barrett et al 194 (2004)</cell><cell>14</cell><cell>14</cell><cell>15.3 reduction on CY-BOCS</cell></row><row><cell>de Haan et al 195 (1998)</cell><cell>12</cell><cell>12</cell><cell>12.4 reduction on CY-BOCS with 66% response rate a</cell></row><row><cell>Vogel et al 196 (2004)</cell><cell>6</cell><cell>12 (2 h per session)</cell><cell>8.2 reduction on Y-BOCS</cell></row><row><cell>Greist et al 197 (2002)</cell><cell>11</cell><cell>11</cell><cell>8.0 reduction on Y-BOCS with 60% response rate b</cell></row><row><cell>Freeman et al 198 (2008)</cell><cell>14</cell><cell>12</cell><cell>8.5 reduction on CY-BOCS with 50% response rate b</cell></row><row><cell>Whittal et al 199 (2005)</cell><cell>12</cell><cell>12</cell><cell>11.3 reduction on Y-BOCS</cell></row><row><cell>Cottraux et al 200 (2001)</cell><cell>16</cell><cell>14</cell><cell>12.1 reduction on Y-BOCS with 96% response rate a</cell></row><row><cell>Lindsay et al 201 (1997)</cell><cell>3</cell><cell>15</cell><cell>17.7 reduction on Y-BOCS</cell></row><row><cell>Fals-Stewart et al 202 (1993)</cell><cell>12</cell><cell>24</cell><cell>8.1 reduction on Y-BOCS</cell></row><row><cell>Storch et al 133 (2011)</cell><cell>12</cell><cell>14</cell><cell>14.3 reduction on CY-BOCS with 81% response rate b</cell></row><row><cell>van Balkom et al 203 (1998)</cell><cell>16</cell><cell>16</cell><cell>7.9 reduction on Y-BOCS</cell></row><row><cell>Intensive Treatment</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Storch et al 124 (2007)</cell><cell>3</cell><cell>14</cell><cell>16.4 reduction on CY-BOCS with 90% response rate b</cell></row><row><cell>Foa et al 117 (2005)</cell><cell>12</cell><cell>25</cell><cell>13.6 reduction on Y-BOCS with 62% response rate b</cell></row><row><cell></cell><cell></cell><cell>(5 sessions per wk for 3 wks,</cell><cell></cell></row><row><cell></cell><cell></cell><cell>2 in-home sessions for 1 wk,</cell><cell></cell></row><row><cell></cell><cell></cell><cell>1 weekly session for 8 wks)</cell><cell></cell></row><row><cell>SRI Augmented with CBT</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Simpson et al 136 (2008)</cell><cell>9</cell><cell>17 (2 per week)</cell><cell>11.2 reduction on Y-BOCS</cell></row></table><note xml:id="_Sryz7rd"><p><s xml:id="_uWHFKTU">a Treatment response determined by reductions $ 25% on CY-BOCS/Y-BOCS.</s><s xml:id="_7exUmgy">b Treatment response determined by either a rating of "very much improved" or "much improved" on the CGI-I.</s><s xml:id="_cT5N8wV">Abbreviations: CBT, cognitive-behavioral therapy; CGI-I, Clinical Global Impression of Improvement; CY-BOCS, Children's Yale-Brown Obsessive Compulsive Scale; OCD, obsessive-compulsive disorder; SRI, serotonin reuptake inhibitor; Y-BOCS, Yale-Brown Obsessive Compulsive Scale.</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_UHnRdMV"><s xml:id="_gcm7juE">Â© Postgraduate Medicine, Volume 124, Issue 1, January 2012, ISSN -0032-5481, e-ISSN -1941-9260 ResearchShare TM : http://www.research-share.com/GetIt</s><s xml:id="_Jp6Ud8v">â€¢ Copyright Clearance Center: http://www.copyright.com</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1"><p xml:id="_T6hQdY7"><s xml:id="_d9MK4EK">Nature, Assessment, and Treatment of OCD Â© Postgraduate Medicine, Volume 124, Issue 1, January 2012, ISSN -0032-5481, e-ISSN -1941-9260</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_2"><p xml:id="_Jn4txbj"><s xml:id="_quY2Sus">Â© Postgraduate Medicine, Volume 124, Issue 1, January 2012, ISSN -0032-5481, e-ISSN -1941-9260</s></p></note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_2a5xEhe">Conflict of Interest Statement</head><p xml:id="_67GqbuM"><s xml:id="_b7vg3uQ">Adam B. Lewin, PhD is a consultant for Otsuka Pharmaceuticals and Prophase, Inc. Tanya K. Murphy, MD receives research funding from the National Institutes of Health, Centers for Disease Control and Prevention,</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_vq89cgC">Abnormal and normal obsessions-a replication</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Salkovskis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Harrison</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6jtZep3">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="549" to="552" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Salkovskis PM, Harrison J. Abnormal and normal obsessions-a replication. Behav Res Ther. 1984;22(5):549-552.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_9EbKkaJ">A naturalistic study of referred children and adolescents with obsessivecompulsive disorder</title>
		<author>
			<persName><forename type="first">G</forename><surname>Masi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Millepiedi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bertini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Milantoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Arcangeli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RvmwdEX">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="673" to="681" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Masi G, Millepiedi S, Mucci M, Bertini N, Milantoni L, Arcangeli F. A naturalistic study of referred children and adolescents with obsessive- compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(7): 673-681.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_n7VKeJN">Florida obsessive-compulsive inventory: development, reliability, and validity</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Kaufman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bagner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_F2nYgBb">J Clin Psychol</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="851" to="859" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Storch EA, Kaufman DA, Bagner D, et al. Florida obsessive-compulsive inventory: development, reliability, and validity. J Clin Psychol. 2007;63(9):851-859.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_sRHVWgF">Psychometric analysis of the Yale-Brown Obsessive-Compulsive Scale Second Edition Symptom Checklist</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Larson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Rasmussen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Goodman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6JPdqne">J Anxiety Disord</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="650" to="656" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Storch EA, Larson MJ, Price LH, Rasmussen SA, Murphy TK, Goodman WK. Psychometric analysis of the Yale-Brown Obsessive- Compulsive Scale Second Edition Symptom Checklist. J Anxiety Disord. 2010;24(6):650-656.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_qakDqCC">Obsessive-compulsive symptoms: the contribution of obsessional beliefs and experiential avoidance</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Abramowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Lackey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Wheaton</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.janxdis.2008.06.003</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XxeZ5XG">J Anxiety Disord</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="160" to="166" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Abramowitz JS, Lackey GR, Wheaton MG. Obsessive-compulsive symptoms: the contribution of obsessional beliefs and experiential avoidance. J Anxiety Disord. 2009;23(2):160-166.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_4XjuvmJ">The Brown Longitudinal Obsessive Compulsive Study: clinical features and symptoms of the sample at intake</title>
		<author>
			<persName><forename type="first">A</forename><surname>Pinto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Mancebo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Eisen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Pagano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Rasmussen</surname></persName>
		</author>
		<idno type="DOI">10.4088/jcp.v67n0503</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_U58pk6Q">J Clin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="703" to="711" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pinto A, Mancebo MC, Eisen JL, Pagano ME, Rasmussen SA. The Brown Longitudinal Obsessive Compulsive Study: clinical features and symptoms of the sample at intake. J Clin Psychiatry. 2006;67(5):703-711.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_8B7TQqs">The role of avoidance in the phenomenology of obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Mcguire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Lewin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Rasmussen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Goodman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7kK2ThN">Compr Psychiatry</title>
		<imprint>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>online ahead of print May 5</note>
	<note type="raw_reference">McGuire JF, Storch EA, Lewin AB, Price LH, Rasmussen SA, Goodman WK. The role of avoidance in the phenomenology of obsessive-compulsive disorder [published online ahead of print May 5, 2011]. Compr Psychiatry.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_UKajRQf">Meta-analysis of the symptom structure of obsessivecompulsive disorder</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Bloch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Landeros-Weisenberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Rosario</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pittenger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Leckman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_csHfPmS">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">165</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1532" to="1542" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bloch MH, Landeros-Weisenberger A, Rosario MC, Pittenger C, Leckman JF. Meta-analysis of the symptom structure of obsessive- compulsive disorder. Am J Psychiatry. 2008;165(12):1532-1542.</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_FgZXxHx">Four-factor structure of obsessive-compulsive disorder symptoms in children, adolescents, and adults</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Rosario</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Baer</surname></persName>
		</author>
		<idno type="DOI">10.1097/chi.0b013e318172ef1e</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CwNxcQT">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="763" to="772" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Stewart SE, Rosario MC, Baer L, et al. Four-factor structure of obsessive-compulsive disorder symptoms in children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2008;47(7): 763-772.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_SQgcwmT">Obsessive-compulsive disorder symptom dimensions show specific relationships to psychiatric comorbidity</title>
		<author>
			<persName><forename type="first">G</forename><surname>Hasler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lasalle-Ricci</forename><surname>Vh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Ronquillo</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.psychres.2005.03.003</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2dhGUXP">Psychiatry Res</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="121" to="132" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hasler G, LaSalle-Ricci VH, Ronquillo JG, et al. Obsessive-compulsive disorder symptom dimensions show specific relationships to psychiatric comorbidity. Psychiatry Res. 2005;135(2):121-132.</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_KQphA5p">Tourette Syndrome Assocation International Consortium for Genetics. Obsessive-compulsive symptom dimensions in affected sibling pairs diagnosed with Gilles de la Tourette syndrome</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Leckman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Pauls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1002/ajmg.b.10001</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dq69vh2">Am J Med Genet B Neuropsychiatr Genet</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="60" to="68" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Leckman JF, Pauls DL, Zhang H, et al; Tourette Syndrome Assoca- tion International Consortium for Genetics. Obsessive-compulsive symptom dimensions in affected sibling pairs diagnosed with Gilles de la Tourette syndrome. Am J Med Genet B Neuropsychiatr Genet. 2003;116B(1):60-68.</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_JHWGvkW">Familiality of factor analysis-derived YBOCS dimensions in OCD-affected sibling pairs from the OCD Collaborative Genetics Study</title>
		<author>
			<persName><forename type="first">G</forename><surname>Hasler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pinto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Greenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_23kFH8T">Biol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="617" to="625" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hasler G, Pinto A, Greenberg BD, et al; OCD Collaborative Genetics Study. Familiality of factor analysis-derived YBOCS dimensions in OCD-affected sibling pairs from the OCD Collaborative Genetics Study. Biol Psychiatry. 2007;61(5):617-625.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_rDRt5fY">Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">D</forename><surname>Mataix-Cols</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wooderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Lawrence</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Brammer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Speckens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Phillips</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XanS3vf">Arch Gen Psychiatry</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="564" to="576" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mataix-Cols D, Wooderson S, Lawrence N, Brammer MJ, Speckens A, Phillips ML. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry. 2004;61(6):564-576.</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_fDghDVw">Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">D</forename><surname>Mataix-Cols</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Rauch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Manzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Jenike</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Baer</surname></persName>
		</author>
		<idno type="DOI">10.1176/ajp.156.9.1409</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gzrz657">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">156</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1409" to="1416" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mataix-Cols D, Rauch SL, Manzo PA, Jenike MA, Baer L. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry. 1999;156(9):1409-1416.</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_uVXZSVx">Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">A</forename><surname>Landeros-Weisenberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Bloch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kelmendi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_P5qxaVS">J Affect Disord</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="175" to="179" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Landeros-Weisenberger A, Bloch MH, Kelmendi B, et al. Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder. J Affect Disord. 2010;121(1-2):175-179.</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_XagcqqU">Obsessivecompulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial</title>
		<author>
			<persName><forename type="first">D</forename><surname>Mataix-Cols</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Marks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Greist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Kobak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Baer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Na4dfe2">Psychother Psychosom</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="255" to="262" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mataix-Cols D, Marks IM, Greist JH, Kobak KA, Baer L. Obsessive- compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial. Psychother Psychosom. 2002;71(5):255-262.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_r7GgerP">Symptom dimensions and cognitive-behavioural therapy outcome for pediatric obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Merlo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Larson</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1600-0447.2007.01113.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WnKZtYV">Acta Psychiatr Scand</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="67" to="75" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Storch EA, Merlo LJ, Larson MJ, et al. Symptom dimensions and cognitive-behavioural therapy outcome for pediatric obsessive-compulsive disorder. Acta Psychiatr Scand. 2008;117(1):67-75.</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_zkbjhAt">Predictors of early adult outcomes in pediatric-onset obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Bloch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Craiglow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Landeros-Weisenberger</surname></persName>
		</author>
		<idno type="DOI">10.1542/peds.2009-0015</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6bTECDY">Pediatrics</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1085" to="1093" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bloch MH, Craiglow BG, Landeros-Weisenberger A, et al. Predictors of early adult outcomes in pediatric-onset obsessive-compulsive disorder. Pediatrics. 2009;124(4):1085-1093.</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_6d7dUun">Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">S</forename><surname>Saxena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Rauch</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0193-953x(05)70181-7</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7rnQu7Y">Psychiatr Clin North Am</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="563" to="586" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note>References</note>
	<note type="raw_reference">Saxena S, Rauch SL. Functional neuroimaging and the neuroanat- omy of obsessive-compulsive disorder. Psychiatr Clin North Am. 2000;23(3):563-586. References</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_c8mhWdw">The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Ruscio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Stein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Chiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Kessler</surname></persName>
		</author>
		<idno type="DOI">10.1038/mp.2008.94</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uft87W2">Mol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="53" to="63" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15(1):53-63.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_h8wFEDg">Predictors of functional impairment in pediatric obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Larson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Muroff</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.janxdis.2009.12.004</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VGtqNZB">J Anxiety Disord</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="275" to="283" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Storch EA, Larson MJ, Muroff J, et al. Predictors of functional impair- ment in pediatric obsessive-compulsive disorder. J Anxiety Disord. 2010;24(2):275-283.</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_EDNbstX">Quality of life and functional impairment in obsessive-compulsive disorder: a comparison of patients with and without comorbidity, patients in remission, and healthy controls</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Huppert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Simpson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Nissenson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Liebowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Foa</surname></persName>
		</author>
		<idno type="DOI">10.1002/da.20506</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qTBdnzB">Depress Anxiety</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="39" to="45" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Huppert JD, Simpson HB, Nissenson KJ, Liebowitz MR, Foa EB. Quality of life and functional impairment in obsessive-compulsive disorder: a comparison of patients with and without comorbidity, patients in remission, and healthy controls. Depress Anxiety. 2009;26(1):39-45.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_mkxpWVJ">Multiple pathways to functional impairment in obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Markarian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Larson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Aldea</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cpr.2009.09.005</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gFmaNJd">Clin Psychol Rev</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="78" to="88" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Markarian Y, Larson MJ, Aldea MA, et al. Multiple pathways to func- tional impairment in obsessive-compulsive disorder. Clin Psychol Rev. 2010;30(1):78-88.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_EBrxJaM">Quality of life in children and adolescents with obsessive-compulsive disorder: base rates, parent-child agreement, and clinical correlates</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Lack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Keeley</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00127-009-0013-9</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_h2P6K6b">Soc Psychiatry Psychiatr Epidemiol</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="935" to="942" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lack CW, Storch EA, Keeley ML, et al. Quality of life in children and adolescents with obsessive-compulsive disorder: base rates, parent-child agreement, and clinical correlates. Soc Psychiatry Psychiatr Epidemiol. 2009;44(11):935-942.</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_UYZxYK8">Impact of obsessive-compulsive disorder on quality of life</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Eisen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Mancebo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pinto</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.comppsych.2005.11.006</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_y4q8WJk">Compr Psychiatry</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="270" to="275" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Eisen JL, Mancebo MA, Pinto A, et al. Impact of obsessive-compulsive disorder on quality of life. Compr Psychiatry. 2006;47(4):270-275.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<monogr>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Lopez</surname></persName>
		</author>
		<title level="m" xml:id="_dZV7US3">The Global Burden of Disease. A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries and Risk Factors in 1990 and Projected to 2020</title>
		<meeting><address><addrLine>Cambridge, MA</addrLine></address></meeting>
		<imprint>
			<publisher>Harvard School of Public Health on behalf of the World Health Organization and the World Bank</publisher>
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Murray CJ, Lopez AD. The Global Burden of Disease. A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard School of Public Health on behalf of the World Health Organization and the World Bank; 1996.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_gGBpVa7">Non-clinical obsessions in a young adolescent population: frequency and association with metacognitive variables</title>
		<author>
			<persName><forename type="first">J</forename><surname>Crye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Laskey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cartwright-Hatton</surname></persName>
		</author>
		<idno type="DOI">10.1348/147608309x468176</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5VKs8M6">Psychol Psychother</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="issue">pt 1</biblScope>
			<biblScope unit="page" from="15" to="26" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Crye J, Laskey B, Cartwright-Hatton S. Non-clinical obsessions in a young adolescent population: frequency and association with metacogni- tive variables. Psychol Psychother. 2010;83(pt 1):15-26.</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_GQZHYu4">Intrusive thoughts in a non-clinical adolescent population</title>
		<author>
			<persName><forename type="first">M</forename><surname>Allsopp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Williams</surname></persName>
		</author>
		<idno type="DOI">10.1007/bf00708211</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qKRkvkU">Eur Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="25" to="32" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Allsopp M, Williams T. Intrusive thoughts in a non-clinical adolescent population. Eur Child Adolesc Psychiatry. 1996;5(1):25-32.</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_dwaHhDD">Abnormal and normal obsessions</title>
		<author>
			<persName><forename type="first">S</forename><surname>Rachman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>De Silva</surname></persName>
		</author>
		<idno type="DOI">10.1016/0005-7967(78)90022-0</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wnKxYqK">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="233" to="248" />
			<date type="published" when="1978">1978</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rachman S, de Silva P. Abnormal and normal obsessions. Behav Res Ther. 1978;16(4):233-248.</note>
</biblStruct>

<biblStruct xml:id="b29">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Researchshare</surname></persName>
		</author>
		<idno type="DOI">10.1089/glre.2016.201011</idno>
		<ptr target="http://www.copyright.com" />
		<imprint/>
	</monogr>
	<note type="raw_reference">ResearchShare TM : http://www.research-share.com/GetIt â€¢ Copyright Clearance Center: http://www.copyright.com</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_Tz5Qnks">Brain-behavior relationships in obsessivecompulsive disorder</title>
		<author>
			<persName><forename type="first">S</forename><surname>Saxena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Bota</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Brody</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hNjBvGK">Semin Clin Neuropsychiatry</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="82" to="101" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Saxena S, Bota RG, Brody AL. Brain-behavior relationships in obsessive- compulsive disorder. Semin Clin Neuropsychiatry. 2001;6(2):82-101.</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_KYH8by6">A meta-analysis of functional neuroimaging in obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Whiteside</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Port</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Abramowitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_y6Tuxu8">Psychiatry Res</title>
		<imprint>
			<biblScope unit="volume">132</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="69" to="79" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Whiteside SP, Port JD, Abramowitz JS. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res. 2004; 132(1):69-79.</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_YEA2hN7">The neural bases of obsessivecompulsive disorder in children and adults</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">V</forename><surname>Maia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Cooney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Peterson</surname></persName>
		</author>
		<idno type="DOI">10.1017/s0954579408000606</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_x927FjZ">Dev Psychopathol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1251" to="1283" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Maia TV, Cooney RE, Peterson BS. The neural bases of obsessive- compulsive disorder in children and adults. Dev Psychopathol. 2008; 20(4):1251-1283.</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_wDYCw2x">Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">S</forename><surname>Saxena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Brody</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>Baxter</surname></persName>
		</author>
		<idno type="DOI">10.1192/s0007125000297870</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xZQBH2Y">Br J Psychiatry Suppl</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="26" to="37" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl. 1998;35:26-37.</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_JbzkK6u">Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited</title>
		<author>
			<persName><forename type="first">L</forename><surname>Menzies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Chamberlain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Laird</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Thelen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Sahakian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">T</forename><surname>Bullmore</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FgESz6Y">Neurosci Biobehav Rev</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="525" to="549" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Menzies L, Chamberlain SR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev. 2008;32(3): 525-549.</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_8rJDUz4">Functional neuroimaging in obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">A</forename><surname>Del Casale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Kotzalidis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rapinesi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_bFx5ZKe">Neuropsychobiology</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="61" to="85" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Del Casale A, Kotzalidis GD, Rapinesi C, et al. Functional neuroimaging in obsessive-compulsive disorder. Neuropsychobiology. 2011;64(2):61-85.</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_HuVzCZe">Neuropsychology of obsessive-compulsive disorder: a review and treatment implications</title>
		<author>
			<persName><forename type="first">S</forename><surname>Greisberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mckay</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0272-7358(02)00232-5</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_aVM3SZ9">Clin Psychol Rev</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="95" to="117" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Greisberg S, McKay D. Neuropsychology of obsessive-compulsive disorder: a review and treatment implications. Clin Psychol Rev. 2003; 23(1):95-117.</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_gzJHw7y">Motor inhibition and cognitive flexibility in obsessivecompulsive disorder and trichotillomania</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Chamberlain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Fineberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Blackwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Robbins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Sahakian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xmF4bVz">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1282" to="1284" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chamberlain SR, Fineberg NA, Blackwell AD, Robbins TW, Sahakian BJ. Motor inhibition and cognitive flexibility in obsessive- compulsive disorder and trichotillomania. Am J Psychiatry. 2006;163(7): 1282-1284.</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_Q3pqJdM">Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Swedo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Pietrini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Leonard</surname></persName>
		</author>
		<idno type="DOI">10.1001/archpsyc.1992.01820090018003</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jvDQsAV">Arch Gen Psychiatry</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="690" to="694" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Swedo SE, Pietrini P, Leonard HL, et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. Arch Gen Psychiatry. 1992;49(9):690-694.</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_DdUjReD">18F]FDG PET study in obsessivecompulsive disorder. A clinical/metabolic correlation study after treatment</title>
		<author>
			<persName><forename type="first">D</forename><surname>Perani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Colombo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bressi</surname></persName>
		</author>
		<idno type="DOI">10.1192/bjp.166.2.244</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_AzuQzWP">Br J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">166</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="244" to="250" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Perani D, Colombo C, Bressi S, et al. [18F]FDG PET study in obsessive- compulsive disorder. A clinical/metabolic correlation study after treat- ment. Br J Psychiatry. 1995;166(2):244-250.</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_Q4wNJJg">FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Brody</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Saxena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Schwartz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JGBpA4G">Psychiatry Res</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="6" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Brody AL, Saxena S, Schwartz JM, et al. FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder. Psychiatry Res. 1998;84(1):1-6.</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_rcCsnD8">Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Stoessel</surname></persName>
		</author>
		<author>
			<persName><surname>Baxter Lr Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Phelps</surname></persName>
		</author>
		<idno type="DOI">10.1001/archpsyc.1996.01830020023004</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Dh33rQh">Arch Gen Psychiatry</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="109" to="113" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schwartz JM, Stoessel PW, Baxter LR Jr, Martin KM, Phelps ME. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry. 1996;53(2):109-113.</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_2ajUkMQ">Twin studies on obsessive-compulsive disorder: a review</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Van Grootheest</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Cath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Beekman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">I</forename><surname>Boomsma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mBZmZ44">Twin Res Hum Genet</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="450" to="458" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">van Grootheest DS, Cath DC, Beekman AT, Boomsma DI. Twin studies on obsessive-compulsive disorder: a review. Twin Res Hum Genet. 2005;8(5):450-458.</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_SP3zhBV">A family study of obsessive-compulsive disorder with pediatric probands</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Hanna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Himle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Curtis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Gillespie</surname></persName>
		</author>
		<idno type="DOI">10.1002/ajmg.b.30138</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NAbngrZ">Am J Med Genet B Neuropsychiatr Genet</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="13" to="19" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hanna GL, Himle JA, Curtis GC, Gillespie BW. A family study of obsessive-compulsive disorder with pediatric probands. Am J Med Genet B Neuropsychiatr Genet. 2005;134B(1):13-19.</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_bvMMT6y">Obsessive compulsive disorder in children and adolescents: phenomenology and family history</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Riddle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Scahill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>King</surname></persName>
		</author>
		<idno type="DOI">10.1097/00004583-199009000-00015</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XGcUNvG">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="766" to="772" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Riddle MA, Scahill L, King R, et al. Obsessive compulsive disorder in children and adolescents: phenomenology and family history. J Am Acad Child Adolesc Psychiatry. 1990;29(5):766-772.</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main" xml:id="_vTTXMjM">A family study of obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Pauls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Alsobrook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Goodman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rasmussen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Leckman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DQ6xxyw">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="76" to="84" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pauls DL, Alsobrook JP 2nd, Goodman W, Rasmussen S, Leckman J. A family study of obsessive-compulsive disorder. Am J Psychiatry. 1995;152(1):76-84.</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_vCEczKp">A family study of early-onset obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>De Rosario-Campos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Leckman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Curi</surname></persName>
		</author>
		<idno type="DOI">10.1002/ajmg.b.30149</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EGgHy35">Am J Med Genet B Neuropsychiatr Genet</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="92" to="97" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">de Rosario-Campos MC, Leckman JF, Curi M, et al. A family study of early-onset obsessive-compulsive disorder. Am J Med Genet B Neurop- sychiatr Genet. 2005;136B(1):92-97.</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main" xml:id="_TByK8mT">The genetics of obsessive-compulsive disorder: a review</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Pauls</surname></persName>
		</author>
		<idno type="DOI">10.31887/dcns.2010.12.2/dpauls</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pjXGrKx">Dialogues Clin Neurosci</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="149" to="163" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pauls DL. The genetics of obsessive-compulsive disorder: a review. Dialogues Clin Neurosci. 2010;12(2):149-163.</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main" xml:id="_DaJBWT6">Association of the SLC1 A1 glutamate transporter gene and obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Fagerness</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Platko</surname></persName>
		</author>
		<idno type="DOI">10.1002/ajmg.b.30533</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Pz9KyBr">Am J Med Genet B Neuropsychiatr Genet</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1027" to="1033" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Stewart SE, Fagerness JA, Platko J, et al. Association of the SLC1 A1 glutamate transporter gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet. 2007;144B(8):1027-1033.</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main" xml:id="_WJ36yn6">A haplotype containing quantitative trait loci for SLC1 A1 gene expression and its association with obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Wendland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Moya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Timpano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rJZB7Qt">Arch Gen Psychiatry</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="408" to="416" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wendland JR, Moya PR, Timpano KR, et al. A haplotype containing quantitative trait loci for SLC1 A1 gene expression and its association with obsessive-compulsive disorder. Arch Gen Psychiatry. 2009;66(4): 408-416.</note>
</biblStruct>

<biblStruct xml:id="b50">
	<monogr>
		<title level="m" type="main" xml:id="_4mKxbYX">Learning Theory and Behavior</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">H</forename><surname>Mowrer</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1960">1960</date>
			<publisher>Wiley</publisher>
			<pubPlace>New York, NY</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Mowrer OH. Learning Theory and Behavior. New York, NY: Wiley; 1960.</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main" xml:id="_7BGxzd9">A cognitive theory of obsessions</title>
		<author>
			<persName><forename type="first">S</forename><surname>Rachman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_eTSyddT">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="793" to="802" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rachman S. A cognitive theory of obsessions. Behav Res Ther. 1997;35(9):793-802.</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main" xml:id="_NhcAMPm">Cognitive-behavioural factors and the persistence of intrusive thoughts in obsessional problems</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Salkovskis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_SEFhQFB">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="677" to="682" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Salkovskis PM. Cognitive-behavioural factors and the persistence of intrusive thoughts in obsessional problems. Behav Res Ther. 1989;27(6):677-682.</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main" xml:id="_bxH8Sk4">Cognitive assessment of obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">Obsessive</forename><surname>Compulsive</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cognitions</forename><forename type="middle">Working</forename><surname>Group</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5mpNzbU">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="667" to="681" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Obsessive Compulsive Cognitions Working Group. Cognitive assess- ment of obsessive-compulsive disorder. Behav Res Ther. 1997;35(7): 667-681.</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main" xml:id="_zMt4XMj">Understanding and treating obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Salkovskis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7M4fb9s">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">suppl 1</biblScope>
			<biblScope unit="page" from="29" to="S52" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Salkovskis PM. Understanding and treating obsessive-compulsive disorder. Behav Res Ther. 1999;37(suppl 1):S29-S52.</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main" xml:id="_p3mEMa4">Disgust in contamination-based obsessive-compulsive disorder: a review and model</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Brady</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Adams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Lohr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_THvv4dY">Expert Rev Neurother</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1295" to="1305" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Brady RE, Adams TG, Lohr JM. Disgust in contamination-based obsessive-compulsive disorder: a review and model. Expert Rev Neu- rother. 2010;10(8):1295-1305.</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main" xml:id="_d9BDWyP">Symptoms of obsessivecompulsive disorder</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Leckman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Grice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Boardman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6Yh3qJT">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">154</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="911" to="917" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Leckman JF, Grice DE, Boardman J, Zhang H. Symptoms of obsessive- compulsive disorder. Am J Psychiatry. 1997;154(7):911-917.</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main" xml:id="_pc7zHM3">Not just right experiences and obsessive-compulsive features: experimental and selfmonitoring perspectives</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Coles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Heimberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">O</forename><surname>Frost</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Steketee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hB3BKE3">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="153" to="167" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Coles ME, Heimberg RG, Frost RO, Steketee G. Not just right expe- riences and obsessive-compulsive features: experimental and self- monitoring perspectives. Behav Res Ther. 2005;43(2):153-167.</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main" xml:id="_jnZnrfs">Potentials and limitations of cognitive treatments for obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Abramowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mckay</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Wz7SqAB">Cogn Behav Ther</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="140" to="147" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Abramowitz JS, Taylor S, McKay D. Potentials and limitations of cognitive treatments for obsessive-compulsive disorder. Cogn Behav Ther. 2005;34(3):140-147.</note>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main" xml:id="_bHW3SkN">Obsessive compulsive disorder</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Frasier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_eUTkfbz">The Medical Basis of Psychiatry</title>
		<editor>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Fatemi</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Clayton</surname></persName>
		</editor>
		<meeting><address><addrLine>Totowa, NJ</addrLine></address></meeting>
		<imprint>
			<publisher>Humana Press</publisher>
			<date type="published" when="2008">2008</date>
			<biblScope unit="page" from="161" to="180" />
		</imprint>
	</monogr>
	<note>3rd ed</note>
	<note type="raw_reference">Murphy TK, Frasier S, Kim S. Obsessive compulsive disorder. In: Fatemi SH, Clayton PJ, eds. The Medical Basis of Psychiatry. 3rd ed. Totowa, NJ: Humana Press; 2008:161-180.</note>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main" xml:id="_w8MTruj">The immunobiology of Tourette&apos;s disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kurlan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Leckman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VN2HmRh">J Child Adolesc Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="317" to="331" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Murphy TK, Kurlan R, Leckman J. The immunobiology of Tourette&apos;s disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward. J Child Adolesc Psychopharmacol. 2010;20(4):317-331.</note>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main" xml:id="_H6mYVF9">Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Swedo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Leonard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Garvey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_bc8CrAG">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">155</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="264" to="271" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998;155(2): 264-271.</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main" xml:id="_dsA5XXn">Immunology of obsessivecompulsive disorder</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Sajid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Goodman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UZtatbb">Psychiatr Clin North Am</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="445" to="469" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Murphy TK, Sajid MW, Goodman WK. Immunology of obsessive- compulsive disorder. Psychiatr Clin North Am. 2006;29(2):445-469.</note>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main" xml:id="_rWvphx8">Obsessive-compulsive disorder in children and adolescents: a review</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Geller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Biederman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shapiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Park</surname></persName>
		</author>
		<idno type="DOI">10.3109/10673229809000309</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4pZfjP2">Harv Rev Psychiatry</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="260" to="273" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Geller DA, Biederman J, Jones J, Shapiro S, Schwartz S, Park KS. Obsessive-compulsive disorder in children and adolescents: a review. Harv Rev Psychiatry. 1998;5(5):260-273.</note>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main" xml:id="_fYVCbfX">Obsessive-compulsive and spectrum disorders in children and adolescents</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Geller</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.psc.2006.02.012</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_bkJaFw7">Psychiatr Clin North Am</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="353" to="370" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Geller DA. Obsessive-compulsive and spectrum disorders in children and adolescents. Psychiatr Clin North Am. 2006;29(2):353-370.</note>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main" xml:id="_dAVqcYY">Developmental aspects of obsessive compulsive disorder: findings in children, adolescents, and adults</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Geller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Biederman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Faraone</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_A6ZAJYr">J Nerv Ment Dis</title>
		<imprint>
			<biblScope unit="volume">189</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="471" to="477" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Geller DA, Biederman J, Faraone S, et al. Developmental aspects of obsessive compulsive disorder: findings in children, adolescents, and adults. J Nerv Ment Dis. 2001;189(7):471-477.</note>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main" xml:id="_fefBMxw">Demographic and clinical features of obsessive-compulsive disorder in children and adolescents</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Hanna</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qDJDcB9">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="19" to="27" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hanna GL. Demographic and clinical features of obsessive-compulsive disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1995;34(1):19-27.</note>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main" xml:id="_Jf75WNZ">Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Swedo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Rapoport</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Leonard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lenane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Cheslow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gJUZ6QF">Arch Gen Psychiatry</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="335" to="341" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Swedo SE, Rapoport JL, Leonard HL, Lenane M, Cheslow D. Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases. Arch Gen Psychiatry. 1989; 46(4):335-341.</note>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main" xml:id="_H9f4YaR">Obsessive-compulsive disorder across developmental trajectory: Clinical correlates in children, adolescents and adults</title>
		<author>
			<persName><forename type="first">L</forename><surname>Farrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Barrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Piacentini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9tkc9SQ">Behav Change</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="103" to="120" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Farrell L, Barrett P, Piacentini J. Obsessive-compulsive disorder across developmental trajectory: Clinical correlates in children, adolescents and adults. Behav Change. 2006;23(2):103-120.</note>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main" xml:id="_XsPhavC">Functional impairment in children and adolescents with obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">J</forename><surname>Piacentini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Bergman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Keller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mccracken</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mz5dUxA">J Child Adolesc Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">suppl 1</biblScope>
			<biblScope unit="page" from="61" to="S69" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Piacentini J, Bergman RL, Keller M, McCracken J. Functional impairment in children and adolescents with obsessive-compulsive disorder. J Child Adolesc Psychopharmacol. 2003;13(suppl 1):S61-S69.</note>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main" xml:id="_ZYwfHwM">Sleep-related problems in pediatric obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Lack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Geffken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Jacob</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Goodman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2ujYdvt">J Anxiety Disord</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="877" to="885" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Storch EA, Murphy TK, Lack CW, Geffken GR, Jacob ML, Goodman WK. Sleep-related problems in pediatric obsessive-compulsive disorder. J Anxiety Disord. 2008;22(5):877-885.</note>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main" xml:id="_ThYjM8g">Adaptive, emotional, and family functioning of children with obsessive-compulsive disorder and comorbid attention deficit hyperactivity disorder</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Sukhodolsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rosario-Campos</forename><surname>Do</surname></persName>
		</author>
		<author>
			<persName><surname>Mc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Scahill</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_z2zMYQH">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1125" to="1132" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sukhodolsky DG, do Rosario-Campos MC, Scahill L, et al. Adaptive, emotional, and family functioning of children with obsessive-compulsive disorder and comorbid attention deficit hyperactivity disorder. Am J Psychiatry. 2005;162(6):1125-1132.</note>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main" xml:id="_maChAT4">Functional impairment in clinical samples of Norwegian and Swedish children and adolescents with obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">R</forename><surname>Valderhaug</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ivarsson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xRsSSxM">Eur Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="164" to="173" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Valderhaug R, Ivarsson T. Functional impairment in clinical sam- ples of Norwegian and Swedish children and adolescents with obsessive-compulsive disorder. Eur Child Adolesc Psychiatry. 2005; 14(3):164-173.</note>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main" xml:id="_Y2nyDbP">com properties of the Child Obsessive-Compulsive Impact Scale-Revised (COIS-R)</title>
		<author>
			<persName><forename type="first">J</forename><surname>Piacentini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Peris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Bergman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jaffer</surname></persName>
		</author>
		<idno>ISSN -1941-9260</idno>
		<ptr target="http://www.research-share.com/GetItâ€¢CopyrightClearanceCenter:http://www.copyright" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_yaXzu4g">J Clin Child Adolesc Psychol</title>
		<idno type="ISSN">-0032-5481</idno>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="645" to="653" />
			<date type="published" when="2007">January 2012. 2007</date>
		</imprint>
	</monogr>
	<note>Functional impairment in childhood OCD: development and psychometrics Postgraduate Medicine</note>
	<note type="raw_reference">Piacentini J, Peris TS, Bergman RL, Chang S, Jaffer M. Functional impairment in childhood OCD: development and psychometrics Â© Postgraduate Medicine, Volume 124, Issue 1, January 2012, ISSN -0032-5481, e-ISSN -1941-9260 ResearchShare TM : http://www.research-share.com/GetIt â€¢ Copyright Clearance Center: http://www.copyright.com properties of the Child Obsessive-Compulsive Impact Scale-Revised (COIS-R). J Clin Child Adolesc Psychol. 2007;36(4):645-653.</note>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main" xml:id="_xCE8cJd">Anxiety and OC spectrum disorders over life cycle</title>
		<author>
			<persName><forename type="first">E</forename><surname>Hollander</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tByCewU">Int J Psychiatry Clin Pract</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="5" to="10" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hollander E. Anxiety and OC spectrum disorders over life cycle. Int J Psychiatry Clin Pract. 2007;11(s2):5-10.</note>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main" xml:id="_PfFMcuX">Correlates of accommodation of pediatric obsessive-compulsive disorder: parent, child, and family characteristics</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Peris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Bergman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Langley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Mccracken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Piacentini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_p59NP8F">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1173" to="1181" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Peris TS, Bergman RL, Langley A, Chang S, McCracken JT, Piacentini J. Correlates of accommodation of pediatric obsessive-compulsive disorder: parent, child, and family characteristics. J Am Acad Child Adolesc Psychiatry. 2008;47(10):1173-1181.</note>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main" xml:id="_3nMmTTz">Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Geller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jenike</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qT82CUx">Acta Psychiatr Scand</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="4" to="13" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Stewart SE, Geller DA, Jenike M, et al. Long-term outcome of pedi- atric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature. Acta Psychiatr Scand. 2004;110(1):4-13.</note>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main" xml:id="_ccJMgrq">Childhood-onset obsessive-compulsive disorder: a tic-related subtype of OCD?</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Eichstedt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Arnold</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3ESkS4S">Clin Psychol Rev</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="137" to="157" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Eichstedt JA, Arnold SL. Childhood-onset obsessive-compulsive disorder: a tic-related subtype of OCD? Clin Psychol Rev. 2001;21(1): 137-157.</note>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main" xml:id="_s596aUs">Correlates of occupational disability in a clinical sample of obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Mancebo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Greenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Grant</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2VPr4MN">Compr Psychiatry</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="43" to="50" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mancebo MC, Greenberg B, Grant JE, et al. Correlates of occupa- tional disability in a clinical sample of obsessive-compulsive disorder. Compr Psychiatry. 2008;49(1):43-50.</note>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main" xml:id="_JmpSakX">Quality of life in anxiety disorders: a comparison of obsessive-compulsive disorder, social anxiety disorder, and panic disorder</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lochner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mogotsi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Du Toit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kaminer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Niehaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Stein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4KWqGQf">Psychopathology</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="255" to="262" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lochner C, Mogotsi M, du Toit PL, Kaminer D, Niehaus DJ, Stein DJ. Quality of life in anxiety disorders: a comparison of obsessive-compulsive disorder, social anxiety disorder, and panic disorder. Psychopathology. 2003;36(5):255-262.</note>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main" xml:id="_TEb2zs9">Quality of life in obsessivecompulsive disorder before and after treatment</title>
		<author>
			<persName><forename type="first">S</forename><surname>Moritz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rufer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fricke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Y3mkAUq">Compr Psychiatry</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="453" to="459" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Moritz S, Rufer M, Fricke S, et al. Quality of life in obsessive- compulsive disorder before and after treatment. Compr Psychiatry. 2005;46(6):453-459.</note>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main" xml:id="_hThn7d3">Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Kessler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Chiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Demler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Merikangas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Walters</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dxv7MPw">Arch Gen Psychiatry</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="617" to="627" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Preva- lence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62(6):617-627.</note>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main" xml:id="_hUmSxNR">A naturalistic exploratory study of the impact of demographic, phenotypic and comorbid features in pediatric obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">G</forename><surname>Masi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Millepiedi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Perugi</surname></persName>
		</author>
		<idno type="DOI">10.1159/000274175</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2Enz2EC">Psychopathology</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="69" to="78" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Masi G, Millepiedi S, Perugi G, et al. A naturalistic exploratory study of the impact of demographic, phenotypic and comorbid features in pediatric obsessive-compulsive disorder. Psychopathology. 2010;43(2):69-78.</note>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main" xml:id="_gEEWcM9">Clinical characteristics of comorbid obsessive-compulsive disorder and bipolar disorder in children and adolescents</title>
		<author>
			<persName><forename type="first">G</forename><surname>Joshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wozniak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Petty</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6w8xEKk">Bipolar Disord</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="185" to="195" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Joshi G, Wozniak J, Petty C, et al. Clinical characteristics of comorbid obsessive-compulsive disorder and bipolar disorder in children and adolescents. Bipolar Disord. 2010;12(2):185-195.</note>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main" xml:id="_u3edBg3">Autistic children as adults: psychiatric, social, and behavioral outcomes</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Rumsey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Rapoport</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Sceery</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rWNhz5z">J Am Acad Child Psychiatry</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="465" to="473" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rumsey JM, Rapoport JL, Sceery WR. Autistic children as adults: psy- chiatric, social, and behavioral outcomes. J Am Acad Child Psychiatry. 1985;24(4):465-473.</note>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main" xml:id="_JxxJn8x">Autistic traits in obsessivecompulsive disorder</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bejerot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Nylander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>LindstrÃ¶m</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Ht7yEfB">Nord J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="169" to="176" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bejerot S, Nylander L, LindstrÃ¶m E. Autistic traits in obsessive- compulsive disorder. Nord J Psychiatry. 2001;55(3):169-176.</note>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main" xml:id="_rgvefqP">Correlates and mediators of functional disability in obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Abramowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Keeley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WZDJAdD">Depress Anxiety</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="806" to="813" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Storch EA, Abramowitz JS, Keeley M. Correlates and mediators of functional disability in obsessive-compulsive disorder. Depress Anxiety. 2009;26(9):806-813.</note>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main" xml:id="_fR96A7x">Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Merlo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Larson</surname></persName>
		</author>
		<idno type="DOI">10.1097/chi.0b013e31816774b1</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uwWHnBW">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="583" to="592" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Storch EA, Merlo LJ, Larson MJ, et al. Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2008;47(5):583-592.</note>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main" xml:id="_S6RF9A9">Clinical predictors of response to cognitive-behavioral therapy for obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Keeley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Merlo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Geffken</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TsX7HRK">Clin Psychol Rev</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="118" to="130" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Keeley ML, Storch EA, Merlo LJ, Geffken GR. Clinical predictors of response to cognitive-behavioral therapy for obsessive-compulsive disorder. Clin Psychol Rev. 2008;28(1):118-130.</note>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main" xml:id="_VzkmuJc">Which SSRI? A metaanalysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Geller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Biederman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Stewart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_BVR3cCW">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1919" to="1928" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Geller DA, Biederman J, Stewart SE, et al. Which SSRI? A meta- analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry. 2003;160(11):1919-1928.</note>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main" xml:id="_Ntu58Rw">Evidence-based assessment of child obsessive compulsive disorder: recommendations for clinical practice and treatment research</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Lewin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Piacentini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rnqjyNB">Child Youth Care Forum</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="73" to="89" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lewin AB, Piacentini J. Evidence-based assessment of child obsessive compulsive disorder: recommendations for clinical practice and treat- ment research. Child Youth Care Forum. 2010;39(2):73-89.</note>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main" xml:id="_E4Nx7wa">Clinical implications of insight assessment in obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">P</forename><surname>Alonso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>MenchÃ³n</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>SegalÃ s</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_yryvM7b">Compr Psychiatry</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="305" to="312" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Alonso P, MenchÃ³n JM, SegalÃ s C, et al. Clinical implications of insight assessment in obsessive-compulsive disorder. Compr Psychiatry. 2008;49(3):305-312.</note>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main" xml:id="_s7rA55S">Correlates of insight among youth with obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Lewin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Bergman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Peris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Mccracken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Piacentini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_srVvcYp">J Child Psychol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="603" to="611" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lewin AB, Bergman RL, Peris TS, Chang S, McCracken JT, Piacentini J. Correlates of insight among youth with obsessive-compulsive disorder. J Child Psychol Psychiatry. 2010;51(5):603-611.</note>
</biblStruct>

<biblStruct xml:id="b93">
	<monogr>
		<title level="m" type="main" xml:id="_dyvF7JX">Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>First</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Spitzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gibbon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Williams</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2002">2002</date>
			<publisher>New York State Psychiatric Institute</publisher>
			<pubPlace>New York, NY</pubPlace>
		</imprint>
	</monogr>
	<note>SCID-I/P</note>
	<note type="raw_reference">First MB, Spitzer RL, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P). New York, NY: New York State Psychiatric Insti- tute; 2002.</note>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main" xml:id="_QmhvkgD">Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version (K-SADS-PL): initial reliability and validity data</title>
		<author>
			<persName><forename type="first">J</forename><surname>Kaufman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Birmaher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Brent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Rao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HJnMbEs">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="980" to="988" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kaufman J, Birmaher B, Brent D, Rao U. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36(7):980-988.</note>
</biblStruct>

<biblStruct xml:id="b95">
	<monogr>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Dinardo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Barlow</surname></persName>
		</author>
		<title level="m" xml:id="_GQaJahA">Anxiety Disorders Interview Schedule for DSM-IV</title>
		<meeting><address><addrLine>Albany, NY</addrLine></address></meeting>
		<imprint>
			<publisher>Graywind Publications, Inc</publisher>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Brown TA, DiNardo PA, Barlow DH. Anxiety Disorders Interview Schedule for DSM-IV. Albany, NY: Graywind Publications, Inc.; 1994.</note>
</biblStruct>

<biblStruct xml:id="b96">
	<monogr>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Silverman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Albano</surname></persName>
		</author>
		<title level="m" xml:id="_4jS5tCE">The Anxiety Disorders Interview Schedule for DSM-IV: Child and Parent Versions</title>
		<meeting><address><addrLine>San Antonio, TX</addrLine></address></meeting>
		<imprint>
			<publisher>Psychological Corporation</publisher>
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Silverman WK, Albano AM. The Anxiety Disorders Interview Schedule for DSM-IV: Child and Parent Versions. San Antonio, TX: Psychological Corporation; 1996.</note>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main" xml:id="_TTda76b">The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Goodman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Rasmussen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HeaVX4t">Arch Gen Psychiatry</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1006" to="1011" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obses- sive Compulsive Scale: I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006-1011.</note>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main" xml:id="_FR4aJ3w">The Yale-Brown Obsessive Compulsive Scale: II. Validity</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Goodman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Rasmussen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_BrE8gw3">Arch Gen Psychiatry</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1012" to="1016" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obses- sive Compulsive Scale: II. Validity. Arch Gen Psychiatry. 1989;46(11): 1012-1016.</note>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main" xml:id="_UFmBsef">Development and psychometric evaluation of the Yale-Brown Obsessive-Compulsive Scale-Second Edition</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Sulkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Geffken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ricketts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Wk ;</forename><surname>Goodman</surname></persName>
		</author>
		<author>
			<persName><surname>Ea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Rasmussen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Larson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Goodman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Rg78jvn">J Clin Psychol</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page">101</biblScope>
			<date type="published" when="2008">2008. 2010</date>
		</imprint>
	</monogr>
	<note>Concurrent validity of the Yale-Brown Obsessive-Compulsive Scale-Symptom Checklist Psychol Assess</note>
	<note type="raw_reference">Sulkowski ML, Storch EA, Geffken GR, Ricketts E, Murphy TK, Goodman WK. Concurrent validity of the Yale-Brown Obsessive- Compulsive Scale-Symptom Checklist. J Clin Psychol. 2008;64(12): 1338-1351. 100. Storch EA, Rasmussen SA, Price LH, Larson MJ, Murphy TK, Goodman WK. Development and psychometric evaluation of the Yale-Brown Obsessive-Compulsive Scale-Second Edition. Psychol Assess. 2010;22(2):223-232. 101</note>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main" xml:id="_MX4us7e">Refining clinical judgment of treatment outcome in obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Lewin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Nadai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Goodman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.psychres.2010.08.021</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8TSkFFh">Psychiatry Res</title>
		<imprint>
			<biblScope unit="volume">185</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">102</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lewin AB, De Nadai AS, Park J, Goodman WK, Murphy TK, Storch EA. Refining clinical judgment of treatment outcome in obsessive-compulsive disorder. Psychiatry Res. 2011;185(3):394-401. 102</note>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main" xml:id="_3Q4ESEc">Defining response in clinical trials for obsessive-compulsive disorder: a signal detection analysis of the Yale-Brown Obsessive Compulsive Scale</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Tolin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Abramowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Diefenbach</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dffDH78">J Clin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page">103</biblScope>
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tolin DF, Abramowitz JS, Diefenbach GJ. Defining response in clini- cal trials for obsessive-compulsive disorder: a signal detection analysis of the Yale-Brown Obsessive Compulsive Scale. J Clin Psychiatry. 2005;66(12):1549-1557. 103</note>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main" xml:id="_8yXmZv3">The Obsessive-Complusive Inventory: development and validation of a short version</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Foa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Huppert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Leiberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JEZJfzR">Psychol Assess</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">104</biblScope>
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Foa EB, Huppert JD, Leiberg S, et al. The Obsessive-Complusive Inventory: development and validation of a short version. Psychol Assess. 2002;14(4):485-496. 104</note>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main" xml:id="_tBdEcX6">The Yale-Brown Obsessive Compulsive Scale: interview versus self-report</title>
		<author>
			<persName><forename type="first">G</forename><surname>Steketee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Frost</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bogart</surname></persName>
		</author>
		<idno type="DOI">10.1016/0005-7967(96)00036-8</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TZAmhUP">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">105</biblScope>
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Steketee G, Frost R, Bogart K. The Yale-Brown Obsessive Compul- sive Scale: interview versus self-report. Behav Res Ther. 1996;34(8): 675-684. 105</note>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main" xml:id="_8mySf2u">Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">K</forename><surname>Benito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kircanski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Peris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Piacentini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_He38c8X">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">108</biblScope>
			<date type="published" when="1998">2011. 1998. 2011</date>
		</imprint>
	</monogr>
	<note>Assessment of obsessive-compulsive disorder: review and future directions Exp Rev Neurother Cognitive-behavioral therapy for obsessive-compulsive disorder in children and adolescents Child Adolesc Psychiatr Clin N Am</note>
	<note type="raw_reference">Benito K, Storch EA. Assessment of obsessive-compulsive disorder: review and future directions. Exp Rev Neurother. 2011;11(2):287-298. 106. Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 1998;37(10 suppl):27S-45S. 107. Kircanski K, Peris TS, Piacentini JC. Cognitive-behavioral therapy for obsessive-compulsive disorder in children and adolescents. Child Adolesc Psychiatr Clin N Am. 2011;20(2):239-254. 108</note>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main" xml:id="_TjdWz87">Children&apos;s Yale-Brown Obsessive Compulsive Scale: reliability and validity</title>
		<author>
			<persName><forename type="first">L</forename><surname>Scahill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Riddle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mcswiggin-Hardin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cwrymc9">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">109</biblScope>
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Scahill L, Riddle MA, McSwiggin-Hardin M, et al. Children&apos;s Yale- Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997;36(6):844-852. 109</note>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main" xml:id="_rJsqhaY">Psychometric evaluation of the Children&apos;s Yale-Brown Obsessive-Compulsive Scale</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Geffken</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5fUFsKt">Psychiatry Res</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">110</biblScope>
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Storch EA, Murphy TK, Geffken GR, et al. Psychometric evaluation of the Children&apos;s Yale-Brown Obsessive-Compulsive Scale. Psychiatry Res. 2004;129(1):91-98. 110</note>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main" xml:id="_e6qfGCQ">Defining treatment response and remission in obsessive-compulsive disorder: a signal detection analysis of the Children&apos;s Yale-Brown Obsessive-Compulsive Scale</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Lewin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Nadai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Bdryvah">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page">111</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Storch EA, Lewin AB, De Nadai AS, Murphy TK. Defining treatment response and remission in obsessive-compulsive dis- order: a signal detection analysis of the Children&apos;s Yale-Brown Obsessive-Compulsive Scale. J Am Acad Child Adolesc Psychiatry. 2010;49(7):708-717. 111</note>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main" xml:id="_9BJZgMZ">The preliminary development of a new self-report measure for OCD in young people</title>
		<author>
			<persName><forename type="first">R</forename><surname>Shafran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Frampton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Heyman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reynolds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Teachman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rachman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GpyDqBq">J Adolesc</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">112</biblScope>
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shafran R, Frampton I, Heyman I, Reynolds M, Teachman B, Rachman S. The preliminary development of a new self-report mea- sure for OCD in young people. J Adolesc. 2003;26(1):137-142. 112</note>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main" xml:id="_3p3jzzM">Children&apos;s Florida Obsessive Compulsive Inventory: psychometric properties and feasibility of a self-report measure of obsessive-compulsive symptoms in youth</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Khanna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Merlo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zncvQUu">Child Psychiatry Hum Dev</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">113</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Storch EA, Khanna M, Merlo LJ, et al. Children&apos;s Florida Obsessive Compulsive Inventory: psychometric properties and feasibility of a self-report measure of obsessive-compulsive symptoms in youth. Child Psychiatry Hum Dev. 2009;40(3):467-483. 113</note>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main" xml:id="_35d5vUe">Development and validation of a child version of the obsessive compulsive inventory</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Foa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Coles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Huppert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">V</forename><surname>Pasupuleti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Franklin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>March</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nScXP5h">Behav Ther</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">114</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Foa EB, Coles M, Huppert JD, Pasupuleti RV, Franklin ME, March J. Development and validation of a child version of the obses- sive compulsive inventory. Behav Ther. 2010;41(1):121-132. 114</note>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main" xml:id="_mNMtkGr">Assessment of pediatric obsessive-compulsive disorder: a critical review of current methodology</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Merlo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Goodman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Geffken</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pskXUbu">Child Psychiatry Hum Dev</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="195" to="214" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Merlo LJ, Storch EA, Murphy TK, Goodman WK, Geffken GR. Assessment of pediatric obsessive-compulsive disorder: a critical review of current methodology. Child Psychiatry Hum Dev. 2005; 36(2):195-214.</note>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main" xml:id="_zZDaK2P">Pediatric OCD Treatment (POTS) Study Team. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Researchshare</surname></persName>
		</author>
		<ptr target="http://www.copyright.com115" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_CdwFCc7">JAMA</title>
		<imprint>
			<biblScope unit="volume">292</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page">116</biblScope>
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">ResearchShare TM : http://www.research-share.com/GetIt â€¢ Copyright Clearance Center: http://www.copyright.com 115. Pediatric OCD Treatment (POTS) Study Team. Cognitive-behavior therapy, sertraline, and their combination for children and ado- lescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA. 2004;292(16):1969-1976. 116</note>
</biblStruct>

<biblStruct xml:id="b113">
	<analytic>
		<title level="a" type="main" xml:id="_vwrGsaG">Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Watson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Rees</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6T6Bmw9">J Child Psychol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">117</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Watson HJ, Rees CS. Meta-analysis of randomized, controlled treat- ment trials for pediatric obsessive-compulsive disorder. J Child Psychol Psychiatry. 2008;49(5):489-498. 117</note>
</biblStruct>

<biblStruct xml:id="b114">
	<analytic>
		<title level="a" type="main" xml:id="_UdA5pbt">Randomized, placebocontrolled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Foa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Liebowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Kozak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_87eCVf2">Clin Psychol Rev</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">119</biblScope>
			<date type="published" when="2005">2005. 2008</date>
		</imprint>
	</monogr>
	<note>Psychological treatment of obsessive-compulsive disorder: a meta-analysis Am J Psychiatry</note>
	<note type="raw_reference">Foa EB, Liebowitz MR, Kozak MJ, et al. Randomized, placebo- controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry. 2005;162(1):151-161. 118. Rosa-AlcÃ¡zar AI, SÃ¡nchez-Meca J, GÃ³mez-Conesa A, MarÃ­n- MartÃ­nez F. Psychological treatment of obsessive-compulsive disorder: a meta-analysis. Clin Psychol Rev. 2008;28(8):1310-1325. 119</note>
</biblStruct>

<biblStruct xml:id="b115">
	<analytic>
		<title level="a" type="main" xml:id="_H4fdRWF">American Psychiatric Association. Practice guideline for the treatment of patients with obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">J</forename><surname>March</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Frances</forename><forename type="middle">A</forename><surname>Carpenter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D ;</forename><surname>Lm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Hanna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hollander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Nestadt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hb ;</forename><surname>Simpson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Kearney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Anstey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Von</forename><surname>Sanden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C ;</forename><surname>Fama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wilhelm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_AWEXYVE">Concepts and Controversies in Obsessive-Compulsive Disorder</title>
		<editor>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Abramowitz</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Houts</surname></persName>
		</editor>
		<meeting><address><addrLine>New York, NY</addrLine></address></meeting>
		<imprint>
			<publisher>Springer</publisher>
			<date type="published" when="1997">1997. 2007. 2006. 2005</date>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page">123</biblScope>
		</imprint>
	</monogr>
	<note>The expert consensus guidelines series: Treatment of Obsessive-compulsive disorder Am J Psychiatry Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescents J Clin Psychiatry Formal cognitive therapy: a new treatment for OCD</note>
	<note type="raw_reference">March J, Frances A, Carpenter D, Kahn D. The expert consensus guidelines series: Treatment of Obsessive-compulsive disorder. J Clin Psychiatry. 1997;58(suppl 4):2-65. 120. Koran LM, Hanna GL, Hollander E, Nestadt G, Simpson HB. American Psychiatric Association. Practice guideline for the treat- ment of patients with obsessive-compulsive disorder. Am J Psychiatry. 2007;164(7 suppl):S5-S53. 121. O&apos;Kearney RT, Anstey KJ, von Sanden C. Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescents. Cochrane Database Syst Rev. 2006;(4):CD004856. 122. Fama J, Wilhelm S. Formal cognitive therapy: a new treatment for OCD. In: Abramowitz JS, Houts AC, eds. Concepts and Controver- sies in Obsessive-Compulsive Disorder. New York, NY: Springer; 2005:263-281. 123</note>
</biblStruct>

<biblStruct xml:id="b116">
	<analytic>
		<title level="a" type="main" xml:id="_FuYSWTx">The effectiveness of treatment for pediatric obsessive-compulsive disorder: a meta-analysis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Abramowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Whiteside</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Deacon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cuKbQXZ">Behav Ther</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">124</biblScope>
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Abramowitz JS, Whiteside SP, Deacon BJ. The effectiveness of treat- ment for pediatric obsessive-compulsive disorder: a meta-analysis. Behav Ther. 2005;36(1):55-63. 124</note>
</biblStruct>

<biblStruct xml:id="b117">
	<analytic>
		<title level="a" type="main" xml:id="_Ekt9xze">Family-based cognitivebehavioral therapy for pediatric obsessive-compulsive disorder: Comparison of intensive and weekly approaches</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Geffken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Merlo</surname></persName>
		</author>
		<idno type="DOI">10.1097/chi.0b013e31803062e7</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_AzBRzRF">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">125</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Storch EA, Geffken GR, Merlo LJ, et al. Family-based cognitive- behavioral therapy for pediatric obsessive-compulsive disorder: Comparison of intensive and weekly approaches. J Am Acad Child Adolesc Psychiatry. 2007;46(4):469-478. 125</note>
</biblStruct>

<biblStruct xml:id="b118">
	<analytic>
		<title level="a" type="main" xml:id="_sG5kAEA">Exposure and ritual prevention for obsessive-compulsive disorder: effects of intensive versus twiceweekly sessions</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Abramowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Foa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Franklin</surname></persName>
		</author>
		<idno type="DOI">10.1037/0022-006x.71.2.394</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_haaJWnj">J Consult Clin Psychol</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">126</biblScope>
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Abramowitz JS, Foa EB, Franklin ME. Exposure and ritual prevention for obsessive-compulsive disorder: effects of intensive versus twice- weekly sessions. J Consult Clin Psychol. 2003;71(2):394-398. 126</note>
</biblStruct>

<biblStruct xml:id="b119">
	<analytic>
		<title level="a" type="main" xml:id="_GXfjKPv">An open trial of intensive family based cognitivebehavioral therapy in youth with obsessive-compulsive disorder who are medication partial responders or nonresponders</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">D</forename><surname>Lehmkuhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ricketts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Geffken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Marien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Murphy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jNeQsnM">J Clin Child Adolesc Psychol</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">127</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Storch EA, Lehmkuhl HD, Ricketts E, Geffken GR, Marien W, Murphy TK. An open trial of intensive family based cognitive- behavioral therapy in youth with obsessive-compulsive disorder who are medication partial responders or nonresponders. J Clin Child Adolesc Psychol. 2010;39(2):260-268. 127</note>
</biblStruct>

<biblStruct xml:id="b120">
	<analytic>
		<title level="a" type="main" xml:id="_bh9nVKm">A maintenance program for obsessive-compulsive disorder using exposure with response prevention: 2-year follow-up</title>
		<author>
			<persName><forename type="first">D</forename><surname>Mckay</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0005-7967(96)00105-2</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jE66gBN">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">128</biblScope>
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McKay D. A maintenance program for obsessive-compulsive disorder using exposure with response prevention: 2-year follow-up. Behav Res Ther. 1997;35(4):367-369. 128</note>
</biblStruct>

<biblStruct xml:id="b121">
	<analytic>
		<title level="a" type="main" xml:id="_YrdSfHW">Cognitive-behavioral family treatment for childhood obsessive-compulsive disorder: a 7-year follow-up study</title>
		<author>
			<persName><forename type="first">O'</forename><surname>Leary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Barrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Fjermestad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_W7mAAvt">J Anxiety Disord</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page">129</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">O&apos;Leary EM, Barrett P, Fjermestad KW. Cognitive-behavioral family treatment for childhood obsessive-compulsive disorder: a 7-year follow-up study. J Anxiety Disord. 2009;23(7):973-978. 129</note>
</biblStruct>

<biblStruct xml:id="b122">
	<analytic>
		<title level="a" type="main" xml:id="_dDuhWNk">The role of treatment expectancy in youth receiving exposure-based CBT for obsessive compulsive disorder</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Lewin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Peris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lindsey</forename><surname>Bergman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mccracken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Piacentini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7fW26t7">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">130</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lewin AB, Peris TS, Lindsey Bergman R, McCracken JT, Piacentini J. The role of treatment expectancy in youth receiving exposure-based CBT for obsessive compulsive disorder. Behav Res Ther. 2011; 49(9):536-543. 130</note>
</biblStruct>

<biblStruct xml:id="b123">
	<analytic>
		<title level="a" type="main" xml:id="_6BP6qP4">Cognitive behavioral therapy plus motivational interviewing improves outcome for pediatric obsessive-compulsive disorder: a preliminary study</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Merlo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">D</forename><surname>Lehmkuhl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RXDYR7E">Cogn Behav Ther</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">131</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Merlo LJ, Storch EA, Lehmkuhl HD, et al. Cognitive behavioral therapy plus motivational interviewing improves outcome for pediatric obsessive-compulsive disorder: a preliminary study. Cogn Behav Ther. 2010;39(1):24-27. 131</note>
</biblStruct>

<biblStruct xml:id="b124">
	<analytic>
		<title level="a" type="main" xml:id="_dXZwCQx">Challenges using motivational interviewing as an adjunct to exposure therapy for obsessivecompulsive disorder</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Simpson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Zuckoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Maher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6kdJcKq">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page">132</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Simpson HB, Zuckoff AM, Maher MJ, et al. Challenges using moti- vational interviewing as an adjunct to exposure therapy for obsessive- compulsive disorder. Behav Res Ther. 2010;48(10):941-948. 132</note>
</biblStruct>

<biblStruct xml:id="b125">
	<analytic>
		<title level="a" type="main" xml:id="_GDEZYPg">The efficacy of an internet-based cognitive-behavioral therapy intervention for child anxiety disorders</title>
		<author>
			<persName><forename type="first">S</forename><surname>March</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Spence</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Donovan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NpdQ2Y9">J Pediatr Psychol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">133</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">March S, Spence SH, Donovan CL. The efficacy of an internet-based cognitive-behavioral therapy intervention for child anxiety disorders. J Pediatr Psychol. 2009;34(5):474-487. 133</note>
</biblStruct>

<biblStruct xml:id="b126">
	<analytic>
		<title level="a" type="main" xml:id="_C7F8Mzp">Preliminary investigation of web-camera delivered cognitive-behavioral therapy for youth with obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">E</forename><surname>Caporino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Morgan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FmJ2kZr">Psychiatry Res</title>
		<imprint>
			<biblScope unit="volume">189</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">134</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Storch EA, Caporino NE, Morgan JR, et al. Preliminary investigation of web-camera delivered cognitive-behavioral therapy for youth with obsessive-compulsive disorder. Psychiatry Res. 2011;189(3):407-412. 134</note>
</biblStruct>

<biblStruct xml:id="b127">
	<analytic>
		<title level="a" type="main" xml:id="_aU66TYj">Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review</title>
		<author>
			<persName><forename type="first">De</forename><surname>Nadai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Mcguire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Lewin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Tk ;</forename><surname>Abramowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_brRMT4d">J Consult Clin Psychol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">136</biblScope>
			<date type="published" when="1997">2011. 1997</date>
		</imprint>
	</monogr>
	<note>Evidence-based pharmacotherapy for pediatric obsessive-compulsive disorder and chronic tic disorders J Cent Nerve Syst Dis</note>
	<note type="raw_reference">De Nadai AS, Storch EA, McGuire JF, Lewin AB, Murphy TK. Evi- dence-based pharmacotherapy for pediatric obsessive-compulsive dis- order and chronic tic disorders. J Cent Nerve Syst Dis. 2011;3:125-142. 135. Abramowitz JS. Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review. J Consult Clin Psychol. 1997;65(1):44-52. 136</note>
</biblStruct>

<biblStruct xml:id="b128">
	<analytic>
		<title level="a" type="main" xml:id="_wV6cQkc">A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Simpson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Foa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Liebowitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5w5gxE2">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">165</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">139</biblScope>
			<date type="published" when="1991">2008. 1991. 1992</date>
		</imprint>
	</monogr>
	<note>The Clomipramine Collaborative Study Group. Clomipramine in the treatment of patients with obsessive-compulsive disorder Am J Psychiatry Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder-a multicenter trial Arch Gen Psychiatry</note>
	<note type="raw_reference">Simpson HB, Foa EB, Liebowitz MR, et al. A randomized, con- trolled trial of cognitive-behavioral therapy for augmenting phar- macotherapy in obsessive-compulsive disorder. Am J Psychiatry. 2008;165(5):621-630. 137. The Clomipramine Collaborative Study Group. Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1991;48(8):730-738. 138. DeVeaugh-Geiss J, Moroz G, Biederman J, et al. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder-a multicenter trial. J Am Acad Child Adolesc Psychiatry. 1992;31(1):45-49. 139</note>
</biblStruct>

<biblStruct xml:id="b129">
	<analytic>
		<title level="a" type="main" xml:id="_DaqZyKZ">Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Stein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Spadaccini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hollander</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_bPXQmVY">Int Clin Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">140</biblScope>
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Stein DJ, Spadaccini E, Hollander E. Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder. Int Clin Psychopharmacol. 1995;10(1):11-18. 140</note>
</biblStruct>

<biblStruct xml:id="b130">
	<analytic>
		<title level="a" type="main" xml:id="_2KqV76C">Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Freeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Trimble</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Deakin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Stokes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Ashford</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_bfpSMva">J Clin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page">141</biblScope>
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Freeman CP, Trimble MR, Deakin JF, Stokes TM, Ashford JJ. Fluvox- amine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison. J Clin Psychiatry. 1994;55(7):301-305. 141</note>
</biblStruct>

<biblStruct xml:id="b131">
	<analytic>
		<title level="a" type="main" xml:id="_zJBdeke">Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Koran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Mcelroy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Davidson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Rasmussen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hollander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Jenike</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ba9FSsa">J Clin Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">142</biblScope>
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Koran LM, McElroy SL, Davidson JR, Rasmussen SA, Hollander E, Jenike MA. Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison. J Clin Psychopharmacol. 1996; 16(2):121-129. 142</note>
</biblStruct>

<biblStruct xml:id="b132">
	<analytic>
		<title level="a" type="main" xml:id="_nWVjYJn">Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Geller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Emslie</surname></persName>
		</author>
		<idno type="DOI">10.1097/01.chi.0000138356.29099.f1</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wFGqcHg">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">143</biblScope>
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Geller DA, Wagner KD, Emslie G, et al. Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a ran- domized, multicenter, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2004;43(11):1387-1396. 143</note>
</biblStruct>

<biblStruct xml:id="b133">
	<analytic>
		<title level="a" type="main" xml:id="_rKuXRja">Placebocontrolled trial of fluoxetine and phenelzine for obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Jenike</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Baer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Minichiello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Rauch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Buttolph</surname></persName>
		</author>
		<idno type="DOI">10.1176/ajp.154.9.1261</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CbVdNPQ">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">154</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">144</biblScope>
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jenike MA, Baer L, Minichiello WE, Rauch SL, Buttolph ML. Placebo- controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder. Am J Psychiatry. 1997;154(9):1261-1264. 144</note>
</biblStruct>

<biblStruct xml:id="b134">
	<analytic>
		<title level="a" type="main" xml:id="_Yu86D3r">Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators</title>
		<author>
			<persName><forename type="first">J</forename><surname>Zohar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Judge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_aH6eQTC">Br J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">145</biblScope>
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zohar J, Judge R. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators. Br J Psychiatry. 1996;169(4):468-474. 145</note>
</biblStruct>

<biblStruct xml:id="b135">
	<analytic>
		<title level="a" type="main" xml:id="_377XZP2">Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Soomro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Altman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rajagopal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M ;</forename><surname>Oakley-Browne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kaplan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hollander</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jFn4xTH">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">147</biblScope>
			<date type="published" when="2003">2008. 2003</date>
		</imprint>
	</monogr>
	<note>Review of pharmacologic treatments for obsessive-compulsive disorder Psychiatr Serv</note>
	<note type="raw_reference">Soomro GM, Altman D, Rajagopal S, Oakley-Browne M. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obses- sive compulsive disorder (OCD). Cochrane Database Syst Rev. 2008;(1):CD001765. 146. Kaplan A, Hollander E. Review of pharmacologic treatments for obsessive-compulsive disorder. Psychiatr Serv. 2003;54(8):1111-1118. 147</note>
</biblStruct>

<biblStruct xml:id="b136">
	<analytic>
		<title level="a" type="main" xml:id="_MwUR76w">Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Bloch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcguire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Landeros-Weisenberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Leckman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pittenger</surname></persName>
		</author>
		<idno type="DOI">10.1038/mp.2009.50</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WPWAkG7">Mol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">148</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bloch MH, McGuire J, Landeros-Weisenberger A, Leckman JF, Pittenger C. Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Mol Psychiatry. 2010;15(8): 850-855. 148</note>
</biblStruct>

<biblStruct xml:id="b137">
	<analytic>
		<title level="a" type="main" xml:id="_gnNE4XJ">Risk of adverse behavioral effects with pediatric use of antidepressants</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Goodman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_aRByjDE">Psychopharmacology (Berl)</title>
		<imprint>
			<biblScope unit="volume">191</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">149</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Goodman WK, Murphy TK, Storch EA. Risk of adverse behavioral effects with pediatric use of antidepressants. Psychopharmacology (Berl). 2007;191(1):87-96. 149</note>
</biblStruct>

<biblStruct xml:id="b138">
	<analytic>
		<title level="a" type="main" xml:id="_QnXnmpD">SSRI adverse events: how to monitor and manage</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Segarra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Goodman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KbpYq6t">Int Rev Psychiatry</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">150</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Murphy TK, Segarra A, Storch EA, Goodman WK. SSRI adverse events: how to monitor and manage. Int Rev Psychiatry. 2008;20(2): 203-208. 150</note>
</biblStruct>

<biblStruct xml:id="b139">
	<analytic>
		<title level="a" type="main" xml:id="_unenzzQ">Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Bridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Iyengar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Salary</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.297.15.1683</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_M2VrJuh">JAMA</title>
		<imprint>
			<biblScope unit="volume">297</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page">151</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric anti- depressant treatment: a meta-analysis of randomized controlled trials. JAMA. 2007;297(15):1683-1696. 151</note>
</biblStruct>

<biblStruct xml:id="b140">
	<analytic>
		<title level="a" type="main" xml:id="_wsNs4mU">Biological approaches to treatment-resistant obsessive compulsive disorder</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Goodman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Mcdougle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Barr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Aronson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lh ;</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Simpson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Huppert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Petkova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Foa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Liebowitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ftrWxFB">J Clin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">153</biblScope>
			<date type="published" when="1993">1993. 2006</date>
		</imprint>
	</monogr>
	<note>Response versus remission in obsessive-compulsive disorder J Clin Psychiatry</note>
	<note type="raw_reference">Goodman WK, McDougle CJ, Barr LC, Aronson SC, Price LH. Biological approaches to treatment-resistant obsessive compulsive disorder. J Clin Psychiatry. 1993;54(suppl):16-26. 152. Simpson HB, Huppert JD, Petkova E, Foa EB, Liebowitz MR. Response versus remission in obsessive-compulsive disorder. J Clin Psychiatry. 2006;67(2):269-276. 153</note>
</biblStruct>

<biblStruct xml:id="b141">
	<analytic>
		<title level="a" type="main" xml:id="_g7DAhqD">com study in patients with and without tics</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Mcdougle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Goodman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Leckman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Heninger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Price</surname></persName>
		</author>
		<ptr target="http://www.copyright" />
	</analytic>
	<monogr>
		<title level="m" xml:id="_ZD34hEZ">Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder: a double-blind, placebo-cotrolled ResearchShare TM</title>
		<imprint>
			<date type="published" when="1994">1994</date>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page">154</biblScope>
		</imprint>
	</monogr>
	<note type="raw_reference">McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder: a double-blind, placebo-cotrolled ResearchShare TM : http://www.research-share.com/GetIt â€¢ Copyright Clearance Center: http://www.copyright.com study in patients with and without tics. Arch Gen Psychiatry. 1994;51(4):302-308. 154</note>
</biblStruct>

<biblStruct xml:id="b142">
	<analytic>
		<title level="a" type="main" xml:id="_r3XbUJ2">Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a doubleblind, placebo-controlled study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Muscatello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bruno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pandolfo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KrHp2UN">J Clin Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">155</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Muscatello MR, Bruno A, Pandolfo G, et al. Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double- blind, placebo-controlled study. J Clin Psychopharmacol. 2011;31(2): 174-179. 155</note>
</biblStruct>

<biblStruct xml:id="b143">
	<analytic>
		<title level="a" type="main" xml:id="_8wzRABv">Aripiprazole augmentation in 39 adolescents with medication-resistant obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">G</forename><surname>Masi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pfanner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Millepiedi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Berloffa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_65XRDfn">J Clin Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">156</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Masi G, Pfanner C, Millepiedi S, Berloffa S. Aripiprazole augmenta- tion in 39 adolescents with medication-resistant obsessive-compulsive disorder. J Clin Psychopharmacol. 2010;30(6):688-693. 156</note>
</biblStruct>

<biblStruct xml:id="b144">
	<analytic>
		<title level="a" type="main" xml:id="_DfkjHKc">A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors</title>
		<author>
			<persName><forename type="first">D</forename><surname>Denys</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>De Geus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Van Megen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">G</forename><surname>Westenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_aV8jSqD">J Clin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">157</biblScope>
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Denys D, de Geus F, van Megen HJ, Westenberg HG. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. J Clin Psychiatry. 2004;65(8):1040-1048. 157</note>
</biblStruct>

<biblStruct xml:id="b145">
	<analytic>
		<title level="a" type="main" xml:id="_4zu9fTb">Adding quetiapine to SRI in treatment-resistant obsessive-compulsive disorder: a randomized controlled treatment study</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Fineberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sivakumaran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gale</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qTWP5WT">Int Clin Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">158</biblScope>
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fineberg NA, Sivakumaran T, Roberts A, Gale T. Adding quetia- pine to SRI in treatment-resistant obsessive-compulsive disorder: a randomized controlled treatment study. Int Clin Psychopharmacol. 2005;20(4):223-226. 158</note>
</biblStruct>

<biblStruct xml:id="b146">
	<analytic>
		<title level="a" type="main" xml:id="_vVKXTmN">Quetiapine addition to serotonin reuptake inhibitors in patients with severe obsessive-compulsive disorder: a double-blind, randomized, placebo-controlled study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kordon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Koch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dNnygVr">J Clin Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">159</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kordon A, Wahl K, Koch N, et al. Quetiapine addition to serotonin reuptake inhibitors in patients with severe obsessive-compulsive disorder: a double-blind, randomized, placebo-controlled study. J Clin Psychopharmacol. 2008;28(5):550-554. 159</note>
</biblStruct>

<biblStruct xml:id="b147">
	<analytic>
		<title level="a" type="main" xml:id="_26uFHwb">Quetiapine augments the effect of citalopram in non-refractory obsessivecompulsive disorder: a randomized, double-blind, placebo-controlled study of 76 patients</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Vulink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Denys</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Fluitman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Meinardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hg ;</forename><surname>Westenberg</surname></persName>
		</author>
		<author>
			<persName><surname>Cj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Epperson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Pelton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wasylink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Price</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_bgQgYY2">Arch Gen Psychiatry</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page">161</biblScope>
			<date type="published" when="2000">2009. 2000</date>
		</imprint>
	</monogr>
	<note>A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder J Clin Psychiatry</note>
	<note type="raw_reference">Vulink NC, Denys D, Fluitman SB, Meinardi JC, Westenberg HG. Quetiapine augments the effect of citalopram in non-refractory obsessive- compulsive disorder: a randomized, double-blind, placebo-controlled study of 76 patients. J Clin Psychiatry. 2009;70(7):1001-1008. 160. McDougle CJ, Epperson CN, Pelton GH, Wasylink S, Price LH. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry. 2000;57(8):794-801. 161</note>
</biblStruct>

<biblStruct xml:id="b148">
	<analytic>
		<title level="a" type="main" xml:id="_hSHAdjt">Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Diniz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Shavitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Pereira</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4trAy9t">J Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">162</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Diniz JB, Shavitt RG, Pereira CA, et al. Quetiapine versus clomip- ramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial. J Psychopharmacol. 2010;24(3):297-307. 162</note>
</biblStruct>

<biblStruct xml:id="b149">
	<analytic>
		<title level="a" type="main" xml:id="_kFVgRKS">A double-blind combination study of clonazepam with sertraline in obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Crockett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Churchill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Davidson</surname></persName>
		</author>
		<idno type="DOI">10.1080/10401230490486972</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FFWSPKa">Ann Clin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">163</biblScope>
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Crockett BA, Churchill E, Davidson JR. A double-blind combination study of clonazepam with sertraline in obsessive-compulsive disorder. Ann Clin Psychiatry. 2004;16(3):127-132. 163</note>
</biblStruct>

<biblStruct xml:id="b150">
	<analytic>
		<title level="a" type="main" xml:id="_DwDRWZK">Secondgeneration antipsychotics for obsessive compulsive disorder</title>
		<author>
			<persName><forename type="first">K</forename><surname>Komossa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Depping</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Kissling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Leucht</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NbVRfG5">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="8141" to="008164" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Komossa K, Depping AM, Meyer M, Kissling W, Leucht S. Second- generation antipsychotics for obsessive compulsive disorder. Cochrane Database Syst Rev. 2010;(12):CD008141. 164.</note>
</biblStruct>

<biblStruct xml:id="b151">
	<analytic>
		<title level="a" type="main" xml:id="_qtp7GrJ">Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessivecompulsive disorder: a 12-week open-label preliminary study</title>
		<author>
			<persName><forename type="first">E</forename><surname>Pessina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Albert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bogetto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Maina</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CVtGj3Y">Int Clin Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">165</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pessina E, Albert U, Bogetto F, Maina G. Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive- compulsive disorder: a 12-week open-label preliminary study. Int Clin Psychopharmacol. 2009;24(5):265-269. 165</note>
</biblStruct>

<biblStruct xml:id="b152">
	<analytic>
		<title level="a" type="main" xml:id="_5fecbP2">Risks from antipsychotic medications in children and adolescents</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Lewin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">D</forename><surname>Storch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rGfKbgj">JAMA</title>
		<imprint>
			<biblScope unit="volume">303</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">166</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lewin AB, Storch EA, Storch HD. Risks from antipsychotic medica- tions in children and adolescents. JAMA. 2010;303(8):729-730. 166</note>
</biblStruct>

<biblStruct xml:id="b153">
	<analytic>
		<title level="a" type="main" xml:id="_CUjTdxp">A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">H</forename><surname>Matsunaga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nagata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hayashida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ohya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kiriike</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Stein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3Xfu9dw">J Clin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">167</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Matsunaga H, Nagata T, Hayashida K, Ohya K, Kiriike N, Stein DJ. A long-term trial of the effectiveness and safety of atypical antipsy- chotic agents in augmenting SSRI-refractory obsessive-compulsive disorder. J Clin Psychiatry. 2009;70(6):863-868. 167</note>
</biblStruct>

<biblStruct xml:id="b154">
	<analytic>
		<title level="a" type="main" xml:id="_srgeqyb">Memantine as an augmenting agent for severe pediatric OCD</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Hezel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Beattie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Stewart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wtybrjh">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">166</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="237" to="168" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hezel DM, Beattie K, Stewart SE. Memantine as an augmenting agent for severe pediatric OCD. Am J Psychiatry. 2009;166(2):237. 168</note>
</biblStruct>

<biblStruct xml:id="b155">
	<analytic>
		<title level="a" type="main" xml:id="_74yVzNT">N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Lafleur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pittenger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kelmendi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kwpr8tD">Psychopharmacology (Berl)</title>
		<imprint>
			<biblScope unit="volume">184</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">169</biblScope>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lafleur DL, Pittenger C, Kelmendi B, et al. N-acetylcysteine augmenta- tion in serotonin reuptake inhibitor refractory obsessive-compulsive disorder. Psychopharmacology (Berl). 2006;184(2):254-256. 169</note>
</biblStruct>

<biblStruct xml:id="b156">
	<analytic>
		<title level="a" type="main" xml:id="_Ykag6QM">Obsessive-compulsive and spectrum disorders: overview and quality of life issues</title>
		<author>
			<persName><forename type="first">E</forename><surname>Hollander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Kwon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Stein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Broatch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Rowland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Himelein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_esPKKGz">J Clin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="issue">suppl 8</biblScope>
			<biblScope unit="page">170</biblScope>
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hollander E, Kwon JH, Stein DJ, Broatch J, Rowland CT, Himelein CA. Obsessive-compulsive and spectrum disorders: overview and quality of life issues. J Clin Psychiatry. 1996;57(suppl 8):3-6. 170</note>
</biblStruct>

<biblStruct xml:id="b157">
	<analytic>
		<title level="a" type="main" xml:id="_5JRwRCB">Clinical characteristics of young people referred to an obsessive compulsive disorder clinic in the United Kingdom</title>
		<author>
			<persName><forename type="first">U</forename><surname>Chowdhury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Frampton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Heyman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uxuREK2">Clin Child Psychol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">171</biblScope>
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chowdhury U, Frampton I, Heyman I. Clinical characteristics of young people referred to an obsessive compulsive disorder clinic in the United Kingdom. Clin Child Psychol Psychiatry. 2004;9(3):395-401. 171</note>
</biblStruct>

<biblStruct xml:id="b158">
	<analytic>
		<title level="a" type="main" xml:id="_QdXMcD3">Treatment of obsessive-compulsive disorder by U.S. psychiatrists</title>
		<author>
			<persName><forename type="first">C</forename><surname>Blanco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Olfson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Stein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Simpson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Gameroff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Narrow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NEKv6AQ">J Clin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">172</biblScope>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Blanco C, Olfson M, Stein DJ, Simpson HB, Gameroff MJ, Narrow WH. Treatment of obsessive-compulsive disorder by U.S. psychiatrists. J Clin Psychiatry. 2006;67(6):946-951. 172</note>
</biblStruct>

<biblStruct xml:id="b159">
	<analytic>
		<title level="a" type="main" xml:id="_BzcNXA8">Effectiveness of intensive residential treatment (IRT) for severe, refractory obsessivecompulsive disorder</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Stack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Farrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Pauls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Jenike</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nRpzDhU">J Psychiatr Res</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">173</biblScope>
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Stewart SE, Stack DE, Farrell C, Pauls DL, Jenike MA. Effectiveness of intensive residential treatment (IRT) for severe, refractory obsessive- compulsive disorder. J Psychiatr Res. 2005;39(6):603-609. 173</note>
</biblStruct>

<biblStruct xml:id="b160">
	<analytic>
		<title level="a" type="main" xml:id="_C7gZWUA">Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">E</forename><surname>Mundo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Maina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Uslenghi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YtfrSwW">Int Clin Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">174</biblScope>
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mundo E, Maina G, Uslenghi C. Multicentre, double-blind, com- parison of fluvoxamine and clomipramine in the treatment of obses- sive-compulsive disorder. Int Clin Psychopharmacol. 2000;15(2): 69-76. 174</note>
</biblStruct>

<biblStruct xml:id="b161">
	<analytic>
		<title level="a" type="main" xml:id="_w9qWEXy">Efficacy of fluvoxamine in obsessive-compulsive disorder: a double-blind comparison with placebo</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Goodman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Rasmussen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Delgado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Heninger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Charney</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MXfGAEp">Arch Gen Psychiatry</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">175</biblScope>
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS. Efficacy of fluvoxamine in obsessive-compulsive disor- der: a double-blind comparison with placebo. Arch Gen Psychiatry. 1989;46(1):36-44. 175</note>
</biblStruct>

<biblStruct xml:id="b162">
	<analytic>
		<title level="a" type="main" xml:id="_43769wQ">Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Goodman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Kozak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Liebowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>White</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_a5uyNZr">Int Clin Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">176</biblScope>
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Goodman WK, Kozak MJ, Liebowitz M, White KL. Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial. Int Clin Psychopharmacol. 1996;11(1):21-29. 176</note>
</biblStruct>

<biblStruct xml:id="b163">
	<analytic>
		<title level="a" type="main" xml:id="_Dh49Jrj">A double-blind, placebocontrolled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">E</forename><surname>Hollander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Koran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Goodman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VW6U7hh">J Clin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">177</biblScope>
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hollander E, Koran LM, Goodman WK, et al. A double-blind, placebo- controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder. J Clin Psychiatry. 2003;64(6):640-647. 177</note>
</biblStruct>

<biblStruct xml:id="b164">
	<analytic>
		<title level="a" type="main" xml:id="_54uQS8A">Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Jenike</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hyman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Baer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VaGUPq5">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">147</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">179</biblScope>
			<date type="published" when="1990">1990. 2001</date>
		</imprint>
	</monogr>
	<note>A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory Am J Psychiatry</note>
	<note type="raw_reference">Jenike MA, Hyman S, Baer L, et al. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory. Am J Psychiatry. 1990;147(9):1209-1215. 178. Riddle MA, Reeve EA, Yaryura-Tobias JA, et al. Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. J Am Acad Child Adolesc Psychiatry. 2001;40(2):222-229. 179</note>
</biblStruct>

<biblStruct xml:id="b165">
	<analytic>
		<title level="a" type="main" xml:id="_3WxBVWZ">Paroxetine in the treatment of obsessive-compulsive disorder: randomized, double-blind, placebocontrolled study in Japanese patients</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kamijima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Murasaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Asai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uhWbdPX">Psychiatry Clin Neurosci</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">180</biblScope>
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kamijima K, Murasaki M, Asai M, et al. Paroxetine in the treatment of obsessive-compulsive disorder: randomized, double-blind, placebo- controlled study in Japanese patients. Psychiatry Clin Neurosci. 2004;58(4):427-433. 180</note>
</biblStruct>

<biblStruct xml:id="b166">
	<analytic>
		<title level="a" type="main" xml:id="_28fwsu5">Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Koran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hackett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rubin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wolkow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Robinson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EDPacup">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">181</biblScope>
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Koran LM, Hackett E, Rubin A, Wolkow R, Robinson D. Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder. Am J Psychiatry. 2002;159(1):88-95. 181</note>
</biblStruct>

<biblStruct xml:id="b167">
	<analytic>
		<title level="a" type="main" xml:id="_hmWFYAx">A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Greist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Jefferson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Kobak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ZSzFzhn">Int Clin Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">182</biblScope>
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Greist JH, Jefferson JW, Kobak KA, et al. A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder. Int Clin Psychopharmacol. 1995; 10(2):57-65. 182</note>
</biblStruct>

<biblStruct xml:id="b168">
	<analytic>
		<title level="a" type="main" xml:id="_FXQejMq">Sertraline in obsessive-compulsive disorder: a doubleblind comparison with placebo</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Jenike</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Baer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Summergrad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Minichiello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Holland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Seymour</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cyDEgjf">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">147</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page">183</biblScope>
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jenike MA, Baer L, Summergrad P, Minichiello WE, Holland A, Seymour R. Sertraline in obsessive-compulsive disorder: a double- blind comparison with placebo. Am J Psychiatry. 1990;147(7): 923-928. 183</note>
</biblStruct>

<biblStruct xml:id="b169">
	<analytic>
		<title level="a" type="main" xml:id="_GazTSkz">Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Kronig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Apter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Asnis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9wuHaU4">J Clin Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">184</biblScope>
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kronig MH, Apter J, Asnis G, et al. Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder. J Clin Psychopharmacol. 1999;19(2):172-176. 184</note>
</biblStruct>

<biblStruct xml:id="b170">
	<analytic>
		<title level="a" type="main" xml:id="_82YEES2">Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study</title>
		<author>
			<persName><forename type="first">R</forename><surname>Bergeron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Ravindran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Chaput</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4y4NfUK">J Clin Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">185</biblScope>
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bergeron R, Ravindran AV, Chaput Y, et al. Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study. J Clin Psychopharmacol. 2002;22(2): 148-154. 185</note>
</biblStruct>

<biblStruct xml:id="b171">
	<analytic>
		<title level="a" type="main" xml:id="_NxQ5Y4s">Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>March</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Biederman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wolkow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_779z3ZK">JAMA</title>
		<imprint>
			<biblScope unit="volume">280</biblScope>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page">186</biblScope>
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note type="raw_reference">March JS, Biederman J, Wolkow R, et al. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter ran- domized controlled trial. JAMA. 1998;280(20):1752-1756. 186</note>
</biblStruct>

<biblStruct xml:id="b172">
	<analytic>
		<title level="a" type="main" xml:id="_wXqHbm7">A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD)</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Montgomery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kasper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Stein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bang</forename><surname>Hedegaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lemming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Om ;</forename><surname>Rad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hakimshooshtary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<idno type="DOI">10.1097/00004850-200103000-00002</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JmxtrKs">Eur Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">188</biblScope>
			<date type="published" when="2001">2001. 2009</date>
		</imprint>
	</monogr>
	<note>Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder Int Clin Psychopharmacol</note>
	<note type="raw_reference">Montgomery SA, Kasper S, Stein DJ, Bang Hedegaard K, Lemming OM. Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder. Int Clin Psychopharmacol. 2001;16(2):75-86. 187. Alaghband-Rad J, Hakimshooshtary M. A randomized controlled clinical trial of citalopram versus fluoxetine in children and adoles- cents with obsessive-compulsive disorder (OCD). Eur Child Adolesc Psychiatry. 2009;18(3):131-135. 188</note>
</biblStruct>

<biblStruct xml:id="b173">
	<analytic>
		<title level="a" type="main" xml:id="_cqkt4FR">Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Stein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Andersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tonnoir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Fineberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rsYBkCW">Curr Med Res Opin</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="701" to="711" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Stein DJ, Andersen EW, Tonnoir B, Fineberg N. Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study. Curr Med Res Opin. 2007;23(4):701-711 189.</note>
</biblStruct>

<biblStruct xml:id="b174">
	<analytic>
		<title level="a" type="main" xml:id="_Rm9BcsH">A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Montgomery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mcintyre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Osterheider</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GdasGVk">Eur Neuropsychopharmacol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">190</biblScope>
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Montgomery SA, McIntyre A, Osterheider M, et al. A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group. Eur Neuropsychopharmacol. 1993;3(2):143-152. 190</note>
</biblStruct>

<biblStruct xml:id="b175">
	<analytic>
		<title level="a" type="main" xml:id="_pfxc8Pr">A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Tollefson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Rampey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Potvin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_eTjRy8r">Arch Gen Psychiatry</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="559" to="567" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tollefson GD, Rampey AH, Potvin JH, et al. A multicenter investiga- tion of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry. 1994;51(7):559-567.</note>
</biblStruct>

<biblStruct xml:id="b176">
	<analytic>
		<title level="a" type="main" xml:id="_Nq9AMQ3">Fluoxetine in children and adolescents with OCD: a placebo-controlled trial</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Researchshare</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Liebowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Piacentini</surname></persName>
		</author>
		<ptr target="http://www" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_SSgTYeC">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page">192</biblScope>
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">ResearchShare TM : http://www.research-share.com/GetIt â€¢ Copyright Clearance Center: http://www.copyright.com 191. Liebowitz MR, Turner SM, Piacentini J, et al. Fluoxetine in children and adolescents with OCD: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2002;41(12):1431-1438. 192</note>
</biblStruct>

<biblStruct xml:id="b177">
	<analytic>
		<title level="a" type="main" xml:id="_AuPWE4m">Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessivecompulsive disorder</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Riddle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Scahill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>King</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GPvrNTn">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">193</biblScope>
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Riddle MA, Scahill L, King RA, et al. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive- compulsive disorder. J Am Acad Child Adolesc Psychiatry. 1992;31(6): 1062-1069. 193</note>
</biblStruct>

<biblStruct xml:id="b178">
	<analytic>
		<title level="a" type="main" xml:id="_rGymcrB">Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Geller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Hoog</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Heiligenstein</surname></persName>
		</author>
		<idno type="DOI">10.1097/00004583-200107000-00011</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_39xXdNe">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page">194</biblScope>
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Geller DA, Hoog SL, Heiligenstein JH, et al; Fluoxetine Pediatric OCD Study Team. Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial. J Am Acad Child Adolesc Psychiatry. 2001;40(7):773-779. 194</note>
</biblStruct>

<biblStruct xml:id="b179">
	<analytic>
		<title level="a" type="main" xml:id="_KdeWBQR">Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial</title>
		<author>
			<persName><forename type="first">P</forename><surname>Barrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Healy-Farrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>March</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vWxp3BT">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">195</biblScope>
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Barrett P, Healy-Farrell L, March JS. Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. J Am Acad Child Adolesc Psychiatry. 2004;43(1):46-62. 195</note>
</biblStruct>

<biblStruct xml:id="b180">
	<analytic>
		<title level="a" type="main" xml:id="_Q9cFxR2">Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">E</forename><surname>De Haan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Hoogduin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Buitelaar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Keijsers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3g2arms">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page">196</biblScope>
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note type="raw_reference">de Haan E, Hoogduin KA, Buitelaar JK, Keijsers GP. Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 1998;37(10):1022-1029. 196</note>
</biblStruct>

<biblStruct xml:id="b181">
	<analytic>
		<title level="a" type="main" xml:id="_4tz48ha">Adding cognitive therapy elements to exposure therapy for obsessive compulsive disorder: a controlled study</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Vogel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Stiles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>GÃ¶testam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kUhtSJn">Behav Cogn Psychother</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">197</biblScope>
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Vogel PA, Stiles TC, GÃ¶testam KG. Adding cognitive therapy elements to exposure therapy for obsessive compulsive disorder: a controlled study. Behav Cogn Psychother. 2004;32(3):275-290. 197</note>
</biblStruct>

<biblStruct xml:id="b182">
	<analytic>
		<title level="a" type="main" xml:id="_RE2cJHF">Behavior therapy for obsessivecompulsive disorder guided by a computer or by a clinician compared with relaxation as a control</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Greist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Marks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Baer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9STcwGm">J Am Acad Child Adolesc Psychiatry</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">199</biblScope>
			<date type="published" when="2002">2002. 2008</date>
		</imprint>
	</monogr>
	<note>Early childhood OCD: preliminary findings from a family-based cognitive-behavioral approach J Clin Psychiatry</note>
	<note type="raw_reference">Greist JH, Marks IM, Baer L, et al. Behavior therapy for obsessive- compulsive disorder guided by a computer or by a clinician compared with relaxation as a control. J Clin Psychiatry. 2002;63(2):138-145. 198. Freeman JB, Garcia AM, Coyne L, et al. Early childhood OCD: pre- liminary findings from a family-based cognitive-behavioral approach. J Am Acad Child Adolesc Psychiatry. 2008;47(5):593-602. 199</note>
</biblStruct>

<biblStruct xml:id="b183">
	<analytic>
		<title level="a" type="main" xml:id="_J3hJGfG">Treatment of obsessivecompulsive disorder: Cognitive behavior therapy vs. exposure and response prevention</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Whittal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Thordarson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Mclean</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.brat.2004.11.012</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YcuGdYy">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page">200</biblScope>
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Whittal ML, Thordarson DS, McLean PD. Treatment of obsessive- compulsive disorder: Cognitive behavior therapy vs. exposure and response prevention. Behav Res Ther. 2005;43(12):1559-1576. 200</note>
</biblStruct>

<biblStruct xml:id="b184">
	<analytic>
		<title level="a" type="main" xml:id="_6p6xUke">A randomized controlled trial of cognitive therapy versus intensive behavior therapy in obsessive compulsive disorder</title>
		<author>
			<persName><forename type="first">J</forename><surname>Cottraux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Note</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Yao</surname></persName>
		</author>
		<idno type="DOI">10.1159/000056269</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_n9EbAzc">Psychother Psychosom</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">201</biblScope>
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cottraux J, Note I, Yao SN, et al. A randomized controlled trial of cognitive therapy versus intensive behavior therapy in obsessive compulsive disorder. Psychother Psychosom. 2001;70(6):288-297. 201</note>
</biblStruct>

<biblStruct xml:id="b185">
	<analytic>
		<title level="a" type="main" xml:id="_szaHM7f">Controlled trial of exposure and response prevention in obsessive-compulsive disorder</title>
		<author>
			<persName><forename type="first">M</forename><surname>Lindsay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Crino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Andrews</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_K5vZACs">Br J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">171</biblScope>
			<biblScope unit="page">202</biblScope>
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lindsay M, Crino R, Andrews G. Controlled trial of exposure and response prevention in obsessive-compulsive disorder. Br J Psychiatry. 1997;171:135-139. 202</note>
</biblStruct>

<biblStruct xml:id="b186">
	<analytic>
		<title level="a" type="main" xml:id="_Ja9AT3Y">A comparison of behavioral group therapy and individual behavior therapy in treating obsessivecompulsive disorder</title>
		<author>
			<persName><forename type="first">W</forename><surname>Fals-Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Marks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schafer</surname></persName>
		</author>
		<idno type="DOI">10.1097/00005053-199303000-00007</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xBQEwaq">J Nerv Ment Dis</title>
		<imprint>
			<biblScope unit="volume">181</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">203</biblScope>
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fals-Stewart W, Marks AP, Schafer J. A comparison of behavioral group therapy and individual behavior therapy in treating obsessive- compulsive disorder. J Nerv Ment Dis. 1993;181(3):189-193. 203</note>
</biblStruct>

<biblStruct xml:id="b187">
	<analytic>
		<title level="a" type="main" xml:id="_mqHYtya">Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Van Balkom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>De Haan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Van Oppen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Spinhoven</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Hoogduin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Van Dyck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YpUjrh9">J Nerv Ment Dis</title>
		<imprint>
			<biblScope unit="volume">186</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="492" to="499" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note type="raw_reference">van Balkom AJ, de Haan E, van Oppen P, Spinhoven P, Hoogduin KA, van Dyck R. Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compul- sive disorder. J Nerv Ment Dis. 1998;186(8):492-499.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
